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Binding of Salivary Proteins to Orthodontic Brackets 
ABSTRACT: 
Objectives: The aim of this study was to investigate the effect of different orthodontic 
materials on the formation of the protein pellicle on the bracket surface.  
Materials and Methods: We used X-ray Photoelectron Spectroscopy (XPS) to analyze 
the atomic composition of orthodontic metallic and ceramic brackets. Following XPS, the 
brackets were immersed in human whole saliva supernatant for 2-hour incubation at 
37C. Hydroxyapatite (HA) discs were used as control. Acquired pellicle was harvested 
with sonication for each group, and liquid chromatography electrospray ionisation mass 
spectrometry was used for protein identification. 
Results: Differences reported by XPS and mass spectrometry were noted among the 
tested groups.  Most of the proteins present on the acquired pellicle were identified 
specifically to each group, indicating little overlap in the acquired pellicle proteins; 84% 
of proteins present on the HA discs were unique to this group, 74% were unique to 
ceramic brackets and 79% were unique to metallic brackets. Despite the fact that most 
proteins were unique to each bracket material, proteins related to antimicrobial, 
lubrication and remineralization biological functions were present in all groups. However, 
proteins associated with inflammatory processes and biofilm formation were found only 
on ceramic brackets. 
Conclusions: The results demonstrate that the protein pellicle formed on the bracket 
surface is dependent on the molecular composition of the bracket. Therefore, our findings 
suggest that modulation of the bracket pellicle via alteration of bracket surface is a 
possibility. 
 
 
Key words: orthodontic brackets, acquired enamel pellicle (AEP), Acquired bracket 
pellicle (ABP), X-ray Photoelectron Spectroscopy (XPS), Mass Spectrometry, LC-ESI-
MS/MS, Protein Identification, Dental caries, white spot lesions (WSL) 
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CHAPTER 1: Orthodontic and Pellicle  
 
 
1.1 Introduction 
A constant concern in the orthodontic clinic is the high prevalence of active carious lesions in 
patients undergoing treatment. In fact, it has been noted that 30 to 70% of patients experience 
active caries lesions during orthodontic treatment (1,2). A Previous study (3) described an alarming 
increase of 2.5 times in active non-cavited carious lesions in orthodontic patients compared with 
the normal population. It is also reported that orthodontic appliances decrease the saliva’s 
buffering capacity and decrease the quantity of salivary -amylase after they are in place for 3 and 
6 months, suggesting that the properties of saliva of orthodontic patients are subject to changes 
(3). This may have a repercussion on the rate of active caries lesions, as the severity of these lesions 
can progress from active white spots to frank cavitation of the enamel. 
 
It is well known that the level of bacterial growth on the surface of the orthodontic brackets is 
variable depending on the material of the bracket (4-6). Furthermore, composite brackets have 
been reported to attract bacterial colonization at a rate higher than any other bracket (7). Several 
studies have focused on the initial bacterial binding to different orthodontic brackets (5,8,9)   trying 
to understand which material is more prone to cariogenic bacterial adhesion. However, there is 
little information in the literature about the protein pellicle that initially adheres to the brackets. 
 
In the oral cavity, it is recognized that specific proteins/peptides have a greater affinity for enamel 
than others, based in part on their surface charges (10). The acquired enamel pellicle (AEP) is a 
thin protein layer formed on the tooth surface that plays a key role in the maintenance of oral health 
by regulating processes such as lubrication, demineralization, and remineralization (11). The AEP 
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also influences the composition of the early microbial flora adhering to tooth surfaces (11). 
Nevertheless, salivary pellicles are not limited to the surface of the tooth. These are also present 
on the oral mucosa (12), dental appliances like orthodontic brackets (8), and even restorations and 
titanium implants (13). 
 
In a previous investigation (14), Liquid Chromatography – ElectroSpray Ionization tandem Mass 
Spectrometry (LC-ESI-MS/MS) was used to investigate the protein composition of the in vivo 
AEP. This study disclosed that this natural film contains at least 130 different proteins. Through 
proteomic analysis, it is possible to discover the salivary components of the AEP. It will be 
interesting to use this advanced technology to understand protein pellicles specific to orthodontic 
brackets, which will provide an awareness and understanding of the future biofilm formation. 
 
The mechanism by which proteins adhere to surfaces is heavily determined by physico-chemical 
properties of the material. Therefore, analyzing the nanostructure of orthodontic brackets, for 
example, may provide important information regarding the reasons why specific proteins may 
selectively adhere to orthodontic fixed appliances. X-ray photoelectron spectrometry (XPS) is a 
powerful tool that gives information about elemental distributions, coating structure and surface 
functionality of materials (15). XPS can detect all elements (except hydrogen and helium) (10) and 
can provide information on particle sizes in the 1-20 nm scale (15).  XPS probes the surface of the 
sample to a depth of 5-10 nanometers (10) and provides a complete profile about the composition 
of a sample near the surface area, which is the region directly in contact with the oral cavity. 
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Since orthodontic treatment lasts for an average of two years, the composition of the protein 
pellicle on the bracket surface, and the consequent biofilm formation, will have a selective impact 
on the abundance of specific oral microorganisms. 
 
The objectives of this study were: 
1. to investigate the molecular composition of two types of orthodontic brackets (metallic and 
ceramic); 
2. to characterize the composition of the acquired protein pellicle formed on the surface of 
the different orthodontic brackets; and 
3. to investigate the correlation between the molecular composition of the bracket surface and 
the proteins identified in the acquired bracket pellicle. 
 
Our findings will attempt to give more information on the uncharacterized acquired bracket pellicle 
for a future possible way to modulate it to reduce oral biofilm formation on the surface of 
orthodontic brackets. 
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1.2 Literature Review: 
1.2.1 Orthodontic treatment and Dental Caries: 
White spot lesions are the precursor of dental cavitation and they are a constant concern for 
clinicians and orthodontic patients. A white spot lesion is the first clinical sign of active dental 
caries, and thus allow for early diagnosis (3). Organic acids produced mainly by cariogenic 
streptococci can be responsible for this demineralization (16). Furthermore, tooth demineralization 
has been reported to be the most common complication of fixed orthodontic treatment, present in 
50% of orthodontic patients (17). In only four weeks, this unaesthetic lesion can appear on the 
surface of the enamel (18). Orthodontic patients are very prone to develop these lesions because 
of the difficulty in maintaining excellent oral hygiene. Most orthodontic patients also wear 
orthodontic adjuvant devices (ex: power chains, open coils, closed coils) that can cause a 
significant increase in plaque retention, possibly compromising their oral health. In addition, it has 
been suggested that metallic orthodontic brackets decrease the salivary pH (19) and increase 
colonization by Streptococcus mutans (20). 
 
Several studies have focused on the initial bacterial binding to different orthodontic brackets 
(5,8,9) trying to understand which material is more prone to cariogenic bacterial adhesion. 
Effectively, the composition of the initial bacterial attachment differs depending on the surface 
material of the bracket (6,21). It has been reported that qualitative and quantitative variations were 
observed on the biofilm after only 30 to 60 mins of intra-oral exposure of different brackets (21). 
Furthermore, it also has been demonstrated that the affinity for Streptococcus mutans is 
significantly lower on metallic brackets compared with the other materials (22). However, little 
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information is available on the adhesion of various proteins to different orthodontic brackets, 
which may impact biofilm formation. 
 
1.2.2 Saliva characteristics: 
1.2.2.1 Saliva definition and composition:  
Saliva is a clear, slightly acidic (pH 6 to 7) and mucoserous exocrine secretion. It contains 99% 
water, electrolytes (sodium, potassium, calcium, chloride, magnesium, bicarbonate, phosphate), 
immunoglobulins, mucins and other proteins. Glucose and nitrogenous products (urea and 
ammonia) are also present in the saliva (23,24). 
 
1.2.2.2 Whole saliva: 
Whole saliva (or total) is a complex fluid mixture derived from major and minor salivary glands, 
crevicular fluid, oral mucosa transudate, mucous of the nasal cavity and pharynx, non-adherent 
oral bacteria, food remainders, desquamated epithelial cells and blood cells. Traces of medications 
or chemical products found in the systemic circulation can also be detected (23). Whole saliva  
include stimulated and unstimulated saliva. 
 
There are different methods available for collecting whole saliva. Common methods include 
spitting, suction, and swab (absorbent), Fejerskov & Kidd (25) reported that salivary composition 
varies according to the nature of the stimulus (gustatory or mechanical) and on the duration. A 
study of unstimulated, chewing-stimulated, and pure parotid saliva has revealed differences in 
metabolite profiles between the three types of saliva (26). These results reinforce the importance 
  
6 
of using the same saliva collection method when comparing protein levels within a study or among 
studies. 
 
1.2.2.3 Salivary glands:  
The major salivary glands include paired parotid, submandibular and sublingual glands. Thousands 
of proteins could be identified in the major salivary glands compare to only 56 proteins in the 
minor salivary glands (27). Minor glands are multiple small glands found around the entire oral 
cavity, except for the gingivae, anterior hard palate and tongue dorsum (28). They contribute  10% 
of the total volume of human saliva (29). They have been reported to have a relative enrichment 
of mucins (MUC5B and MUC7) and immunoglobulins (8 different types) (27). Siqueira reported 
that there is a unique protein composition from minor salivary gland saliva (27). Cystatins, large 
salivary-proline-rich protein family, histatins and 12 new salivary proteins have been noted (27).  
 
 1.2.2.4 Salivary flow: 
At rest, there is a small and continuous salivary flow of 0.3-0.5 mL/min (28). During that 
unstimulated state, the percentage contributions of the salivary glands are 20% from the parotids 
and 65% from submandibular (24).  Furthermore, the unstimulated flow rate from all the minor 
salivary glands in the mouth has been reported to 7–8% of the unstimulated flow rate of whole 
saliva (29). 
Stimulated saliva is produced by a mechanical, gustatory, olfactory or pharmacological stimulus. 
It represents 80-90% of daily salivary production (23). The percentage contribution of the parotid 
salivary glands drastically change to more than 50% when saliva is stimulated (30). 
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The saliva rate and the concentration level of salivary components vary according to the time of 
the day (31). Circadian low flow occurs during sleep, and peaks during stimulation periods (24). 
The unstimulated flow rate for parotid, submandibular and whole saliva attain a peak value around 
15h30 and fall virtually to zero during sleep (32). This has a big implication in preventive dentistry.  
The age of the subject can also be a factor on protein concentration of the unstimulated saliva (33). 
For stimulated saliva, protein concentration can change depending on the flow rate, the nature of 
the stimulus, the duration of the stimulation, the circadian rhythm and the effects of previous 
exercise (32,34,35).  
 
The saliva is first formed inside the acini; this saliva is isotonic with respect to plasma. It becomes 
hypotonic after it runs through the network of ducts (36). There is a low level of glucose, sodium, 
chloride and urea in the hypotonic saliva that allows the dissolution of substances and allows the 
gustatory buds to perceive different flavors. One important protein for the growth and maturation 
of the gustatory buds is gustatin (24). 
Both sympathetic and parasympathetic nerve fibers innervate the salivary glands. When 
sympathetic innervation takes control, the salivary secretions contain more proteins (mucous). 
However, when the parasympathetic system dominates, the saliva will be more serous (30). 
 
1.2.2.5 Type of secretion: 
The saliva is first secreted in the acinar cells, these cells  determine the type of secretion produced 
from the different salivary glands. There are three types of secretions: serous, mucous or mixed. 
The principal producer of serous secretions are the parotid glands and mucous secretions come 
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from the minor glands. Mixed secretions (mucous and serous) are in general produced by the 
sublingual and submandibular glands (24). 
 
Parotid saliva contains amylase, proline-rich proteins and agglutinins. It also contains some 
amount of cystatins, lysozymes and extraparotid glycoproteins (24). Furthermore, parotid glands 
are by far the main source of amylase in whole saliva, but doesn’t secrete mucins (34). In 
consequence, the percentage contribution of parotid to whole saliva will influence the relative 
proteins proportions. Sublingual saliva consists of a high concentration of both types of mucins 
(MUC5B and MUC7) and high levels of lysozymes (24). Furthermore, palatine secretions will 
have important concentration of MUC5B mucins and relatively high amylase concentrations (37).  
 
1.2.2.6 Role of saliva: 
Salivary function can be separated into 5 major groups for maintaining oral health and creating an 
appropriate ecologic balance. The five major roles are: (1) lubrication and protection, (2) buffering 
action and clearance, (3) maintenance of tooth integrity, (4) antibacterial activity, and (5) taste and 
digestion (38,39). 
Lubrication and protection of the oral tissues against irritating agents is possible due to mucins 
(24).  Macromolecules (proteins and mucins) will also serve to cleanse, aggregate and attach oral 
microorganism. This will have an impact on dental plaque metabolism (24). 
The importance of buffering capacity of the saliva will prevent colonization by potential 
pathogenic microorganism. Effectively, bicarbonate, phosphates and urea will modulate the pH 
and the buffering capacity of saliva (24). Bicarbonate is the most important buffering system 
because it diffuses into plaque and neutralize acids (24). Furthermore, peptides rich in histidine 
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also are direct buffers after diffusion into the plaque (40). When salivary flow increases, the 
concentrations of total protein, sodium, calcium, chloride, bicarbonate and the pH will increase to 
different levels, but the concentration of inorganic phosphate and magnesium will decrease (24). 
 
Enamel demineralization prevention by neutralizing the acids, coming from acidogenic 
microorganism, is possible due to calcium, phosphate, fluoride and proteins (11). The mechanisms 
by which AEP proteins (histatins, statherin and mucins) contribute to the enamel demineralization 
protection maybe be related on retarding enamel loss during acid challenges (11).  
 
The antibacterial function comes from the immunoglobulins (IgA, IgG and IgM), proteins and 
enzymes (lactoferin, lysozymes and peroxidase) present in the saliva. IgA, however, is the largest 
immunologic component of saliva (24). 
 
1.2.2.7 Proteins: 
Salivary proteins are multifunctional, they can be functionally redundant, and they can act both for 
and against the host (41). Statherins, histatins, cystatins, and proline-rich proteins are proteins 
present in the protective pellicle, acquired enamel pellicle (AEP). They bind to hydroxyapatite and 
help control the crystalline growth of the enamel.  They limit the dissolution of the minerals and 
allow the penetration of minerals into the enamel (24). 
Proteins such as glycoproteins, statherins, agglutinins, histatins, and proline-rich proteins can 
aggregate bacteria to reduce their ability to adhere to hard/soft tissue surfaces. This in turn will 
control bacterial, fungal, and viral colonization (24). 
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Histatins: 
Negative salivary proteins like histatin 1 have been reported to have a strong affinity to 
hydroxyapatite (HA) discs and they are considered pellicle precursors (10). Research has shown 
that histatins 1 have a buffering function, as well as strong antifungal and antibacterial activities 
(42). They can also modulate mineral formation and provide a protection against acid injury (43).  
 
Statherin: 
Statherin is a low molecular weight protein and is negatively charged. It can inhibit primary and 
secondary calcium phosphate precipitation (10). This will inevitably affect the control of dental 
calculus formation and remineralization of early dental caries (10). Statherin also facilitates the 
binding of Actinomyces viscous (45) and Fusobacterium nucleatum (46), determinant initial 
microbial colonizers of tooth surface. 
 
Cystatins: 
Human saliva contains multiple forms of cystatins; they all belong to family 2 of the cystatin 
superfamily (47). Some cystatins can have a neutral pI (cystatin SN) and others an acidic pI 
(cystatin SA) (47). Cystatins are considered as one of the most abundant proteins in the AEP on 
in situ studies (11). It demonstrates an affinity to mineral surfaces and can also inhibit calcium 
phosphate precipitation (48). Cystatins play an important role in maintaining the integrity of 
teeth (48).  
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Proline-Rich-Proteins (PRP) : 
Proline-rich proteins are major components of parotid and submandibular human saliva. They can 
be divided into three groups; glycosylated, basic and acidic proline-rich proteins. The unique 
structure of the acidic proline-rich proteins doesn’t belong to any known protein family. 
Furthermore, this protein has a role on the inhibition of hydroxyapatite formation.  (49).  
 
Mucins: 
Mucins are proteins with a high carbohydrate content. MUC5B and MUC7 are the major members 
of the salivary mucin family (27). They are synthesized and secreted by submandibular, sublingual 
and minor salivary glands (50). In the oral cavity, they play an integral role in non-immune 
protection (51). They are responsible for lubrication, and protection against desiccation and 
environmental insult. They also have an important antimicrobial effect against potential pathogens 
(51). Effectively, they can modulate the adhesion of microorganisms to the oral tissue surfaces, 
and in consequence they contribute to the control of bacterial and fungal colonisation (51). 
Furthermore, mucins form complexes with other salivary proteins such as amylase, statherin, 
histatin and PRPs (52). These complexes may protect the proteins from enzymatic degradation or 
may enhance their function (27). They also facilitate daily functions such as mastication, speech 
and deglutition through their lubrication effect (24).  
 
MUC5B is a high molecular weight gel forming mucin, it plays a role on the viscoelasticity of 
saliva (53). It has  a high affinity for hydroxyapatite (54) and is a component of the acquired enamel 
pellicle (55).  MUC7 on the other hand, is a low molecular weight monomeric mucin and has 
demonstrated affinity for cementum (56). It also binds to bacteria such oral Streptococci (13).  
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1.2.3 Acquired Enamel Pellicle: 
 
  1.3.3.1 Definitions 
 
The acquired enamel pellicle (AEP) (10) is a thin film acquired on the surface of the teeth when 
exposed to the oral environment. This thin protein film can range from 0.1-1.0 µm in thickness. It 
is formed by a selective adsorption of many salivary proteins, but carbohydrates and lipids are also 
present. This protein film is involved in the demineralization-remineralization process. Because of 
its ideal location (between the enamel and biofilm), it will act as a natural diffusion barrier (10). 
 
1.3.3.2 Proteomic Analysis 
The molecular structure of the AEP has been difficult to assess, because of the very low quantity 
of in vivo formed pellicle that can be harvested from the tooth surface (57). It has been estimated 
that the amount of AEP that can be collected per tooth surface is approximately 0.5-1 µg (58). This 
will prevent the characterization of this protein film with classical biochemical technologies. The 
use of hydroxyapatite discs has been used to gain insights into the AEP (14). Therefore, in vitro 
and in situ studies have provided information on the affinity of salivary proteins with 
hydroxyapatite surfaces. 
 
By using proteomics technologies (59), a study demonstrated that at least 200 proteins spots were 
detectable in AEP in a 2-D gel eletrophoretogram. But 2-D gels are limited by the dependence on 
protein separation, the visualization of proteins in the gel, and the labor-intensive processing of 
excised proteins spots. Mass spectrometric analysis (LC ESI MS/MS), in another hand, can 
generate a protein profile and sequence information. This allows a direct analysis of extremely 
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complex biological samples (14) and helps to characterize the peptides down to the femtomole 
level (14).  
 
One of the persistent challenges in saliva proteomics is the collection and the storing of saliva 
under conditions that maintain protein structure. Because we need minimal proteolysis, 
deglycosylation and dephosphorylation prior to proteomic analysis (34), is important to keep the 
samples on ice during saliva collection and to store the samples at -80ºC (34).  
Furthermore, because protein concentrations change depending on different factors (60), 
standardization of collection conditions is crucial for achieving reliable identification of salivary 
proteins (34). 
 
1.3.3.3 Composition and Function of AEP 
AEP has multiple functions such as neutralizing acid production by oral bacteria, acting as a 
lubrication film, protecting the teeth from abrasive forces (14). Because AEP can dictate the 
composition of initial microbial tooth colonizers, the AEP can ultimately modulate the oral biofilm 
and the mature plaque (61) and can have an impact on dental caries formation (14). 
 
Previous research reported a total of 130 different proteins/peptides in the AEP (14). These 
proteins comprise members of the histatin, statherin, and acidic proline-rich protein (PRP) family 
(14). Multiple in vitro studies report that histatins, statherins, and acidic PRPs have been shown to 
be among the first proteins that adsorb on the hydroxyapatite surface (45,62). 
Past research (14), has also identified the origin of the proteins. They noted a low value of 14.4% 
of all proteins derivate from exocrine salivary secretions, 85.6% originated from non-exocrine 
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contributors to whole saliva (comprising cells (67.8%) and serum (17.8%)) (14). They concluded 
that it is possible that more proteins will be identified as salivary glandular secretions with future 
studies (14). 
Four main groups forming the AEP have been identified in past research (14), when proteins are 
grouped according to their chemical properties. (Figure 1). 
 
 
Figure 1: Classification of AEP proteins by their chemical properties.  (14) 
 
The first group is proteins that can bind calcium ions (17.5% of identified AEP proteins). They 
include S100 calcium binding protein family and members of the annexin family. They are 
considered pellicle precursor proteins due to their affinity to the calcium ions on the enamel 
surface. The other group (15.4%) are proteins that have a high tendency to bind to phosphate ions, 
such as elongation factor 2 and myosin-9, which are also in the primary protein layer because of 
their phosphate affinity. The third group (28.2%) identified in the literature (14) are proteins that 
have an interaction with other protein, such as MUC5B, which are suspected to be involved in the 
formation of the successive protein layers. 
Classification	of	AEP	proteins	by	their	chimical	
properties
Protein/protein	Interaction	:	28.2% Unknown:	38.9%
Calcium	binding	:	17.5% Phosphate	binding	:	15.4%
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The other way that AEP proteins have been categorized are accoding to their biological function. 
Some proteins have remineralization capacities such as calgranulin and annexin families. Other 
proteins like cystatins (S, SA, A, B, D), lysozyme, lactotransferrin, myeloperoxidase, calgranulin 
A, and calgranulin B are essential for oral host defense against pathogens. These proteins are 
involved in the acquired immune response (11.3%) or antimicrobial activity (8.3%) (14) (Figure 
2). 
 
 
Figure 2. Classification of AEP proteins by their biological function.  (14) 
 
It has been noted that the level of gingival inflammatory disease can also have an impact on the 
AEP, therefore albumin, alpha-1-antitrypsin, cathepsin G, complement C3, and myeloperoxidase 
have been identified in the AEP components. These biomarkers for periodontal disease constitute 
13% of the total number of AEP proteins (14). 
 
 
 
 
 
 
Classification	of	AEP	proteins	by	their	biological	functions
Unknown	function	:	51.2% Antimicrobial:	8.3%
Immune	Response	:	11.3% Remineralization	:15.5%
Inflammatory	process:	12.5% Buffer	capacity	:<1%
Lubrification	:	<1%
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1.3.3.4 Salivary pellicles on orthodontic brackets: 
 
Salivary pellicles are not limited to the surface of the tooth. These are also present on the oral 
mucosa (12), dental appliances like orthodontic brackets (8), and even restorations and titanium 
implants (13). 
 
Bacterial adhesion to the surface of orthodontic brackets involve a specific lectin-like reaction 
(63), electrostatic interactions and Van der Waals forces (64). Initial attachment of bacteria is an 
important factor that influences further colonization. The composition of the initial bacterial 
attachment differs depending on the surface material of the orthodontic bracket (6,21). Recent 
studies have found that composite brackets exhibit greater biofilm formation when compared to 
metallic and ceramic brackets (7).  Fournier et al. (22) also found that the affinity for Streptococcus 
mutans was significantly lower on metallic brackets compared with the other materials. 
 
Amylase, secretory IgA, acidic proline-rich proteins, and cystatins adhere to all kinds of brackets. 
However, when an electrophoresis approach was used, the differences in the gel profiles depending 
on the bracket material was evident, showing the selective nature of salivary protein binding  (6). 
The largest differences observe was on the plastic brackets where acidic PRPs were more evident 
(6). Besides, Lee (8) reported that the pellicle components on metal brackets, were almost the same 
as those on the elastomeric ligature ring, with the exception that MG1 was not present on the 
ligature ring. Also, the degree of adhesion of cariogenic streptococci was significantly higher for 
bonding adhesives than for bracket materials (65). 
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The main factor for adhesion of Streptococci to orthodontic brackets are the bracket type, the 
incubation time and the saliva coating. Past studies also reported that differences can be found 
between the protein adsorption on the manufactured metal bracket and the raw metal material, due 
to surfaces properties that can change with manufacturing (8). 
 
Besides, S. gordonii has been found to adhere to orthodontic brackets by a factor of 10 times more 
than S. mutans, which suggests that S. godonii can be the initial colonizer on the orthodontic 
brackets (6). 
 
Higher critical surface tension, higher wettability and higher roughness of the material are 
variables that will have an impact on promoting biofilm adhesion (21). Surface free energy have 
been reported to be higher on stainless steel (SS) orthodontic brackets than ceramic brackets (21). 
According to that finding, bacterial adhesion should be greater on SS brackets. However, Lim et 
al (65) report less cariogenic streptococci adhesion on SS brackets. They concluded that a low 
association between surface energy and bacterial adhesion is because of others factors like surface 
roughness, surface charge and hydrophobicity. 
 
Knowing that each biomaterial has unique chemical properties and surface energies, we suspect 
that proteins will bind differently depending on the properties of the orthodontic brackets. 
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1.2.4 Composition of Orthodontic Brackets: 
1.2.4.1 Metallic orthodontic brackets: 
There are different materials used for manufacturing orthodontic brackets including metals, 
plastics and ceramics. Stainless steel brackets are commonly used (66) because they have 
appropriate physical properties, good corrosion resistance and are affordable. Stainless steel is 
available as type 304, 316 and 17-4 PH SS. Most orthodontic (66) brackets are made from AISI 
type 304L SS, which contains 18-20% chromium and 8-10% nickel. They also have a small 
amount of manganese and silicon, plus a low carbon content (0.03% and less). Some manufacturers 
use type 316L SS, with higher nickel content, 2-3 % molybdenum, and a lower carbon content for 
better welding characteristics (66). Table 1 represent common elements documented by an 
orthodontic company for the composition of their SS orthodontic brackets. 
 
Furthermore, the base and the wings of the brackets are mostly austenitic-type stainless steel alloys 
(303L, 304L, 316L, PH-14-4) and Titanium can also been found (67). The mesh is attached to the 
base by using brazing methods for stainless steel orthodontic brackets. Brazing fillers alloys need 
to be used between the bracket base and wing interface. Most SS alloys can be brazed with several 
different filler metal families, including: Silver, Nickel, Copper, and Gold (67). 
 
Table 1: Composition of SS orthodontic brackets (reported by AO company) 
Components % by Weight 
Silicon, Si 0 to 1.0 
Manganese, Mn 0 to 2.0 
Chromium, Cr 13 to 23 
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Nickel, Ni 3 to 14 
Molybdenum, Mo 0.5 to 3 
Copper, Cu 1.25 to 5 
Niobium, Nb 0.15 to 0.45 
Iron, Fe 50-80 
  
Others elements may be present such as Carbon, Sulfur and Phosphorus. These are not 
hazardous or below 0.1% by weight. 
 
The metallic brackets are fabricated by three main methods: casting, metal injection molding 
(MIM), and milling (68). The most recent technique is MIM, which is less expensive compared to 
the two others techniques. However, the best precision of bracket slot size is accomplished by 
milling the slot of a cast bracket (72).  
 
1.2.4.2 Ceramic Orthodontic brackets 
Aesthetics has become an important aspect when patients choose to have braces. Ceramic brackets 
are often used, they are made of high-purity aluminum oxide, and can be available in two forms; 
polycrystalline and monocrystalline. The monocrystalline brackets have the advantage of 
containing fewer impurities and having an excellent optical clarity. 
Composition of ceramic brackets has been reported to be 100% Aluminum Oxide. A previous 
study (70) showed a variety of structural, compositional, and topographical characteristics when 
they analyzed ceramic brackets from different companies. They found the presence of single-
crystal aluminum oxide (Al2O3), polycrystalline Al2O3, or Al2O3 and silicon oxide (SiO2). They 
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also reported different brackets with rough or smooth bases. The rough areas on the bases consisted 
of sharp crystals or spherical glass particles. 
 
1.2.5 X-Ray Photoelectron Spectroscopy (XPS) 
XPS is a powerful tool for understanding the nature of many different types of surfaces, it can 
provide abundant information about elemental distribution, thickness, and surface functionality 
(15). XPS can detect all elements (except hydrogen and helium) (10) and can provide information 
on particle sizes on the 1-20 nm scale (15).  XPS probes the surface of the sample to a depth of 5-
10 nanometers (10). In other words, because the electron link to the XPS only travel a certain 
specific distance, it can only provide a complete information about the composition of a sample 
near a surface region (15). 
Because electrons, can travel a short distance within a material without losing energy, we can 
measure the surface composition of a material, this is also possible because there is a multitude of 
past research about how nanostructure influences the peak intensities, signal background and the 
binding energies of photoelectron peaks of nanostructure materials. For example, the instrument 
can be calibrated to give a binding energy of 83.96 eV for the Au 4f7/2 line for metallic gold and 
the spectrometer dispersion can be adjusted to give a binding energy of 932.62 eV for the Cu 2p3/2 
line of metallic copper (10). The other elements will be relative to this calibration. 
 
XPS on the surface of the orthodontic bracket is very relevant, because it is providing qualitative 
information on the elements present at the bracket surface and it is to this surface that proteins and 
bacteria will adhere. This adherence will potentially cause a biofilm and can initiate caries lesions 
on the surround areas. 
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1.2.6   ElectroSpray Ionization tandem Mass Spectrometry (LC-ESI-MS/MS) 
Mass spectrometric analysis (LC ESI MS/MS), can generate a protein profile and sequence 
information and allows characterization of peptides down to the femtomole level (14). This allows 
a direct analysis of extremely complex biological samples (14).  
A research report (28) on phosphoproteome exploration using mass spectrometry was challenging 
because of the dissociation of phosphate groups during collision induced dissociation 
fragmentation step, which will hide the location of the phosphorylation sites. One of the solutions 
reported in the literature is the initiation exploration of the phosphoproteome of saliva using a 
chemical derivatization of the phospho-serine/ threonine-containing proteins and covalent 
disulfide-inter-change chromatography to capture and enrich phospho-peptides followed by 
intensive MS analysis, where the MS/ MS data define the location of the P-Ser and/or P-Thr resi-
dues within the amino-acid sequence. That technique allows a better comprehensive study of the 
phosphocreatine (28,71). 
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CHAPTER 2  
 
Binding of Salivary Proteins to Orthodontic Brackets 
INTRODUCTION 
A constant concern in the orthodontic clinic is the high prevalence of active caries lesions in 
patients undergoing treatment. In fact, it has been noted that 30 to 70% of patients experience 
active caries lesions during orthodontic treatment (1,2). Since orthodontic treatment lasts for an 
average of two years, the composition of the protein pellicle on the bracket surface, and the 
consequent biofilm formation, will have an important impact on the abundance of specific oral 
microorganisms. 
 
The mechanism by which proteins adhere to surfaces is heavily determined by physico-chemical 
properties of the material. Therefore, analyzing the nanostructure of orthodontic brackets, for 
example, may provide important information regarding the reasons why specific proteins may 
selectively adsorb to orthodontic fixed appliances. X-ray photoelectron spectrometry (XPS) is a 
powerful tool that gives a multitude of information about elemental distributions and surface 
functionality of materials (3). XPS can detect all elements (except hydrogen and helium) (4) and 
can provide information on particle sizes in the 1-20 nm scale (3).  XPS probes the surface of the 
sample to a depth of 5-10 nm (4) and provides a complete profile about the atomic structure of the 
surface area. 
 
Salivary pellicles are not limited to the surface of the tooth, they are also present on the surface of 
the oral mucosa (5), on prosthetic restorations (6), and on dental appliances like orthodontic 
brackets (7). The acquired enamel pellicle (AEP) is a thin protein layer formed on the tooth surface 
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that plays a key role in the maintenance of oral health by regulating processes such as lubrication, 
demineralization, and remineralization (8). In previous investigation (9), Liquid Chromatography 
– ElectroSpray Ionization tandem Mass Spectrometry (LC-ESI-MS/MS) was used to investigate 
the protein composition of the in vivo AEP. This study disclosed that this natural film contains at 
least 130 different proteins. Through proteomic analysis, it is possible to discover the salivary 
components of the AEP and understand their functions. It will be fruitful to use this advanced 
technology to understand the protein pellicle specific to orthodontic brackets.  This will provide 
an awareness and understanding of the future biofilm formation. 
 
It is well known that the level of bacterial growth on the surface of the orthodontic brackets is 
variable depending on the material of the bracket (10-12). Furthermore, composite brackets have 
been reported to attract bacterial colonization at a rate higher than any other bracket (13). Several 
studies have focused on the initial bacterial binding of different orthodontic brackets (7,11,14)   
trying to understand which material is more prone to cariogenic bacterial adhesion. However, there 
is little information in the literature about the protein pellicle that initially adheres to the brackets 
and consequently leads to biofilm formation.  
 
The purposes of this study were to investigate the molecular composition of two types of 
orthodontic brackets (metallic and ceramic) as well as to characterize the composition of the 
acquired protein pellicle formed on the surface of the different orthodontic brackets.  
 
MATERIALS AND METHODS 
X-ray Photoelectron Spectroscopy  
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X-ray Photoelectron Spectroscopy (XPS) was used to atomically analyze the composition of 
orthodontic metallic brackets (1.1/2.1 bracket) from American Orthodontics company, ceramic 
brackets (1.1/2.1 bracket) from the same company and hydroxyapatite discs (5 mm dia x 1.5-1.8 
mm thick Himed inc.). Each bracket and disc were cleaned 5 minutes by sonication in 800 µL 
distilled water. Immediately after that, one bracket of each group and one discs were incubated for 
2 hours at 37C in 800 µL MiliQ water. Subsequently, XPS atomic analysis was performed on the 
incubated and not incubated samples.  
XPS was calibrated with the same parameters used before (4). The instrument work function was 
calibrated to give a binding energy (BE) of 83.96 eV for the Au 4f7/2 line for metallic gold and 
the spectrometer dispersion was adjusted to give a BE of 932.62 eV for the Cu 2p3/2 line of 
metallic copper. The Kratos charge neutralizer system was performed on all specimens. Survey 
scan analysis were accomplished with an area of 300x700 µm and a pass energy of 160 eV. Spectra 
were analyzed using CasaXPS software (version 2.3.14). Every manipulation was repeated three 
times in order to have triplicates.  
 
Whole saliva collection 
Ethics approval was obtained from Research Human Ethics Board of Western University 
(registration number IRB 00000940) and each subjects of this study received an informed consent. 
Whole saliva from three healthy subjects (2 females and 1 male) aged from 30-40 years old was 
collected in the morning between 8h45 and 9h45 under masticatory stimulation using parafilm 
(25cm2). Subjects were not allowed to eat or drink two hours before saliva collection. Saliva 
samples were kept on ice to minimize protein degradation during the collection procedure. After 
collection, all samples were centrifuged at 14,000xg for 20 minutes at 4C. Following the 
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centrifugation, whole saliva supernatant (WSS) was separated from the pellet and pooled together 
for the use in this experiment. The protein concentration of this pooled sample was measured by 
the bicinchonic acid (BCA) assay (Pierce Chemical, Rockford, IL, USA) with bovine serum 
albumin used as the standard.  Pooled supernatant saliva (µl) was measured and each bracket was 
incubated in 200 µg of total protein (Appendix 1). 
 
Incubation of Metallic and Ceramic Brackets with Human Saliva 
Brackets and HA discs (4 specimens / group) were exposed to 800 µL of distilled water for 2 h at 
37˚C with gentle agitation (in 24 well culture plate). Subsequently, the pre-treated brackets and 
HA discs were incubated for 2 h at 37˚C with WSS containing 800 µg of total protein. Immediately 
after protein incubation period, the HA discs and brackets were washed using distilled water to 
remove any weak binding salivary protein.  
 
Harvesting of in vitro Acquired Bracket Pellicle  
Acquired Bracket Pellicle (ABP) and Acquired Hydroxyapatite Pellicle (AHP) formed on each of 
the brackets and disc surface (n=4/ for each group) were harvested by sonication in 300 µL of 
solution containing 80% acetonitrile, 19.9% water and 0.1% Trifluoroacetic acid (TFA) for 5 min. 
This procedure was repeated three times. Because the small amount of protein that can be harvest 
from one group (n=3), eluted pellicle material from the same group (from the triplicates) were 
pooled and concentrated by a rotary evaporator, in total we pooled 12 brackets of the same group 
and 12 HA discs. The total protein concentration was assessed by the micro bicinchoninic acid 
(Micro BCA) assay (Appendix #2). 
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In–solution Digestion 
The equivalent of 15 μg of pellicle protein was separated from each group and placed into one 
polypropylene microcentrifuge tube. Dried samples were re-suspended in 50 μL of 4 M urea, 10 
mM DTT and 50 mM ammonium bicarbonate at pH 7.8 and incubated for 1 hour at room 
temperature. Afterwards, 150 μL of 50 mM ammonium bicarbonate was added to all samples, 
followed by 3% (w/w) trypsin (Promega, Madison, WI, USA). Thereafter, samples were incubated 
for 16 h at 37 °C. Finally, the samples were dried in a rotary evaporator, de-salted by C-18 ZipTip® 
Pipette Tips (Millipore, Billerica, MA, USA), and subjected to mass spectrometry. 
 
Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS) 
After trypsinization, samples were subjected to nanoscale LC-ESI-MS/MS. All samples were dried 
by rotary evaporator and re-suspended in 15 µL of 97.5 % H2O/2.4% acetonitrile/0.1% formic acid 
and then subjected to reversed-phase LC-ESI-MS/MS. Mass spectrometric analysis was carried 
out with nano-HPLC Proxeon (Thermo, San Jose, CA, USA), which allows in-line liquid 
chromatography with the capillary column, 75 µm x 10 cm (Pico TipTM EMITTER, New 
Objective, Woburn, MA) packed in-house using Magic C18 resin of 5 µm diameter and 200 Å 
pores size (Michrom BioResources, Auburn, CA) linked to mass spectrometer (LTQVelos, 
Thermo Scientific, San Jose, CA, USA) using an electrospray ionization in a survey scan in the 
range of m/z values 390–2000 tandem MS/MS. The nano-flow reversed-phase HPLC was 
developed with linear 80 minutes’ gradient ranging from 5% to 55% of solvent B (97.5% 
acetonitrile, 0.1% formic acid) in 65 minutes at a flow rate of 300 nl/min with a maximum pressure 
of 280 bar. Electrospray voltage and the temperature of the ion transfer capillary were 1.8 kV and 
250 ºC respectively. Each survey scan (MS) was followed by automated sequential selection of 
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seven peptides for collision-induced dissociation (CID), with dynamic exclusion of the previously 
selected ions. 
 
Data Analysis 
The obtained MS/MS spectra were searched against human protein databases (Swiss Prot and 
TrEMBL, Swiss Institute of Bioinformatics, Geneva, Switzerland, http:// expasy.org/sprot) using 
SEQUEST (PROTEOMS Discover 3.0, Thermo, San Jose, CA, USA). Search results were filtered 
for a false discovery rate of 1% employing a decoy search strategy utilizing a reverse database. 
Each sample is analyzed four consecutive time by the mass spectrometry, in order to have a 
positive identification of proteins, the same protein passing the filter score need to be identified 
from at least three different MS analysis from the same group in a total of four MS analyses per 
group. 
 
 
RESULTS 
XPS analysis of metallic orthodontic brackets are shown in Table 1 and Figure 1. We noticed that 
there is a huge variation in the percentage of identified elements on the analysis samples. The 
concentration of silver, iron, niobium, palladium and chromium were variable from one metallic 
bracket to the other (Table 1).  
Proteome identification on the different surface materials incubated with distilled water showed a 
total of 356 proteins in HA control group (DMQ), 298 proteins in metallic orthodontic brackets 
(BMQ) and 156 proteins on ceramic orthodontic brackets (CBMQ) (Table 2; Figure 3). 
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Only 9 proteins were common on these three groups, 36 proteins were common between metallic 
brackets and HA discs; and 18 proteins were common between SS brackets and ceramic brackets 
(Table 3). The vast majority of these proteins were identified specifically in one group indicating 
little overlap in the acquired pellicle proteins (Figure 3). Effectively, 84% of proteins present on 
the HA discs are unique to this group, 74% were unique to ceramic brackets and 79% were unique 
to SS brackets. 
 
Based on MS/MS ion count from each peptide/protein, the 20 most abundant proteins present on 
the SS bracket pellicle, 4 had an isoelectronic point lower than 6 (pI<6), 6 had a pI between 6-8 
and 10 had a pI higher than 8. For the ceramic brackets, 4 proteins had a pI less than 6, 12 had a 
pI between 6-8 and 4 had a pI higher than 8. 
The 20 most abundant proteins on each group are presented on Table 4. These proteins are selected 
depending on their ion count score. The higher the ion count score the higher the probability that 
the protein is present in the sample.  
 
When these proteins were categorized by biological functions (Table 5), it was observed that 
ceramic brackets have different proteins responsible for antibacterial and antifungal properties 
such as immunoglobulin, S-100 and lactotransferrin when compared with HA discs and SS 
brackets.  
 
Proteins responsible for remineralization of the tooth are present such as Histatin-1 for SS bracket 
and HA discs and protein S-100 for ceramic bracket. Statherin was also present on SS brackets. 
Saliva amylase, protein responsible for early plaque formation is present on ceramic brackets and 
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HA discs but not found on SS bracket. Inflammatory proteins such as albumin and S-100 were 
only found on ceramic brackets.  
 
DISCUSSION  
In this study, we characterized the atomic composition of the surface of metallic and ceramic 
orthodontic brackets, and identified differences among the proteins that adhere to each of the 
studied surfaces.  
 
To evaluate the relationship between the surface of the material and the adherence of the proteins, 
XPS analysis was performed on the surface of the orthodontic brackets. The chemical composition 
of this surface will regulate which functional proteins species can interact with the surface (15). 
Therefore, this will modulate the bacteria adhesion with the molecular structure of the adsorbed 
protein layer (16).  
 
While looking at the replicate experiments to analyse the surface of SS brackets, XPS results 
showed a high variability. This high variability on the elements may be due to the brazing process 
used during the fabrication of the brackets (Appendix 3).  
Knowing that proteins possess different net charges, we were not surprise to see that the bracket 
surfaces attract proteins with positive and negative charges without preference for one over the 
other. The overall net charge of orthodontic brackets material is usually neutral (17,18), but we 
can have areas on different material that have a positive or negative charge (15). This is also 
reinforced by the proteome profile of the 20 most abundant proteins identified in each group, with 
positive and negative proteins on the surfaces of both types of brackets. However, the charge of a 
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protein is not the only factor that affects its interaction with a given surface. The size, structure, 
stability and unfolding rate of a protein plays crucial roles in their binding capacity. Furthermore, 
the composition of the surfaces as well as the topography, hydrophobicity and heterogeneity of the 
material are also factors (15) that need to be studied in the future. 
 
In relation to protein identification, there were significant percentages of proteins that were 
identified specifically to each group, suggesting specificity of the protein’s adsorption in relation 
to the surface of the bracket. As a result, biofilm formation (4) and bacterial adhesion (15) will 
very likely be different among the tested brackets. Because the proteins identified on the surface 
of the HA discs are very different from those identified on the surface of the brackets, and knowing 
that HA discs mimic the surface of the tooth (4), these results suggest that SS and ceramic brackets 
have unique protein-adsorption properties that differ from human tooth enamel. Besides finding 
that most proteins are unique to each bracket material, we found that, among the 20 most abundant 
proteins for each group, proteins responsible for antimicrobial activity, lubrication and 
remineralisation function are present in both bracket materials. However, inflammatory proteins 
and proteins responsible of dental plaque formation were found only on ceramic brackets, when 
the 20 most abundant proteins for each group were considered in the two different orthodontic 
material.  
 
One of the proteins that was uniquely identified in the pellicle formed on the ceramic orthodontic 
brackets when compared with SS brackets was amylase. A previous study suggests that salivary 
alpha-amylase binds very selectively and with high affinity to several streptococcal species (19). 
This is likely to influence commensal bacterial colonization (20) and to increase the sucrase and 
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transferase activities of S. mutans (21). Furthermore, starch may intensify the adhesion of amylase-
binding streptococci to dental pellicles and increase the formation of dental plaque (19). Our 
finding is consistent with a previous study that suggests that ceramic brackets show greater affinity 
for Streptococcus mutans when compared to metallic brackets (22).  
 
On the other hand, mucins were found in both bracket groups. Mucins are proteins with a high 
carbohydrate content. MUC5B and MUC7 are the major members of the salivary mucin family 
(23). MUC5B is a high molecular weight gel forming mucin, has a high affinity for hydroxyapatite 
(24), and is a component of the acquired enamel pellicle (25). MUC7, on the other hand, is a low 
molecular weight monomeric mucin and demonstrated affinity for cementum (26). It also can bind 
to bacteria such oral Streptococci (27). Overall, mucins play an integral role in non-immune 
protection (28) and they can modulate the adhesion of microorganisms to the oral tissue surfaces, 
and in consequence they contribute to the control of bacterial and fungal colonisation(28). 
Furthermore, mucins form complexes with other salivary proteins such as amylase, statherin, 
histatin and PRPs (29). These complexes may protect the proteins from enzymatic degradation or 
may enhance their function (23).  
 
Another protein family which appears to have high affinity for ceramic surfaces are cystatins. 
However, no cystatins were found on SS brackets (7). Cystatins possess antimicrobial activity 
against oral pathogens involved in periodontal diseases such as Aggregatibacter 
actinomycetemcomitans (30). Their function also includes the formation of the acquired pellicle 
through their interaction with hydroxyapatite and they play an important role in maintaining the 
integrity of teeth (31).  
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In this study, histatin 1 was identified only on SS brackets. Histatin 1 possesses strong antifungal 
properties against Candida albicans (32). Furthermore, modulation of mineral formation, 
antibacterial activity (33,34) and protection against acid injury (35) have been reported as 
biological functions of histatin 1.  
 
The initial adsorption of the proteins is an important factor for further bacteria colonization. As 
expected, the majority of proteins are different when the orthodontic material changes.  Further 
investigations on bacteria adhesion depending on the bracket pellicle is needed.   
 
CONCLUSIONS 
 
• Our research suggests that the adsorbed protein layer, and in consequence the biofilm, will 
be different depending on the surface of the bracket material.  
• Significant differences were noted between the different types of brackets, suggesting that 
there is a possibility that ceramic brackets increase the  susceptibility to white spot lesions 
and caries.  
• This study opens avenues for changes in the bracket surface as a possible way to modulate 
the acquired bracket pellicle to our advantage. 
 
REFERENCES 
1. Heymann GC, Grauer D. A contemporary review of white spot lesions in orthodontics. J Esthet 
Restor Dent 2013, Apr;25(2):85-95. 
  
40 
2. Enaia M, Bock N, Ruf S. White-spot lesions during multibracket appliance treatment: A 
challenge for clinical excellence. Am J Orthod Dentofacial Orthop 2011, Jul;140(1):e17-24. 
3. Baer DR, Engelhard MH. XPS analysis of nanostructured materials and biological surfaces. 
Journal of Electron Spectroscopy and Related Phenomena 2010;178:415-32. 
4. Siqueira WL, Bakkal M, Xiao Y, Sutton JN, Mendes FM. Quantitative proteomic analysis of 
the effect of fluoride on the acquired enamel pellicle. PLoS One 2012;7(8):e42204. 
5. Bradway SD, Bergey EJ, Jones PC, Levine MJ. Oral mucosal pellicle. Adsorption and 
transpeptidation of salivary components to buccal epithelial cells. Biochem J 1989, Aug 
1;261(3):887-96. 
6. Lin NJ. Biofilm over teeth and restorations: What do we need to know? Dental Materials 2017. 
7. Lee SJ, Kho HS, Lee SW, Yang WS. Experimental salivary pellicles on the surface of 
orthodontic materials. Am J Orthod Dentofacial Orthop 2001, Jan;119(1):59-66. 
8. Siqueira WL, Custodio W, McDonald EE. New insights into the composition and functions of 
the acquired enamel pellicle. J Dent Res 2012, Dec;91(12):1110-8. 
9. Siqueira WL, Zhang W, Helmerhorst EJ, Gygi SP, Oppenheim FG. Identification of protein 
components in in vivo human acquired enamel pellicle using LC-ESI-MS/MS. J Proteome Res 
2007, Jun;6(6):2152-60. 
10. Ryu HS, Bae IH, Lee KG, Hwang HS, Lee KH, Koh JT, Cho JH. Antibacterial effect of silver-
platinum coating for orthodontic appliances. Angle Orthod 2012, Jan;82(1):151-7. 
11. van Gastel J, Quirynen M, Teughels W, Pauwels M, Coucke W, Carels C. Microbial adhesion 
on different bracket types in vitro. Angle Orthod 2009, Sep;79(5):915-21. 
12. Ahn SJ, Kho HS, Lee SW, Nahm DS. Roles of salivary proteins in the adherence of oral 
streptococci to various orthodontic brackets. J Dent Res 2002, Jun;81(6):411-5. 
  
41 
13. Brandão GA, Pereira AC, Brandão AM, de Almeida HA, Motta RR. Does the bracket 
composition material influence initial biofilm formation? Indian J Dent Res 2015;26(2):148-51. 
14. do Nascimento LE, Pithon MM, dos Santos RL, Freitas AO, Alviano DS, Nojima LI, et al. 
Colonization of streptococcus mutans on esthetic brackets: Self-ligating vs conventional. Am J 
Orthod Dentofacial Orthop 2013, Apr;143(4 Suppl):S72-7. 
15. Dee KC, Puleo DA, Bizios R. An introduction to tissue-biomaterial interactions. Cell Mol. 
Biol 2004;8:419-25. 
16. Latour RA. Biomaterials: Protein-surface interactions. Encyclopedia of Biomaterials and 
Biomedical Engineering 2005;1:270-8. 
17. Balzarotti A, Bianconi A. Electronic structure of aluminium oxide as determined by x-ray 
photoemission. Physica Status Solidi (b) 1976;76(2):689-94. 
18. Hermas AA, Nakayama M, Ogura K. Enrichment of chromium-content in passive layers on 
stainless steel coated with polyaniline. Electrochimica Acta 2005;50(10):2001-7. 
19. Scannapieco FA, Torres GI, Levine MJ. Salivary amylase promotes adhesion of oral 
streptococci to hydroxyapatite. J Dent Res 1995, Jul;74(7):1360-6. 
20. Nikitkova AE, Haase EM, Scannapieco FA. Taking the starch out of oral biofilm formation: 
Molecular basis and functional significance of salivary α-amylase binding to oral streptococci. 
Appl Environ Microbiol 2013, Jan;79(2):416-23. 
21. Chaudhuri B, Rojek J, Vickerman MM, Tanzer JM, Scannapieco FA. Interaction of salivary 
alpha-amylase and amylase-binding-protein A (abpa) of streptococcus gordonii with 
glucosyltransferase of S. Gordonii and streptococcus mutans. BMC Microbiol 2007, Jun 25;7:60. 
22. Fournier A, Payant L, Bouclin R. Adherence of streptococcus mutans to orthodontic brackets. 
American Journal of Orthodontics and Dentofacial Orthopedics 1998;114(4):414-7. 
  
42 
23. Siqueira WL, Salih E, Wan DL, Helmerhorst EJ, Oppenheim FG. Proteome of human minor 
salivary gland secretion. J Dent Res 2008, May;87(5):445-50. 
24. Tabak LA, Levine MJ, Jain NK, Bryan AR, Cohen RE, Monte LD, et al. Adsorption of human 
salivary mucins to hydroxyapatite. Arch Oral Biol 1985;30(5):423-7. 
25. Al-Hashimi I, Levine MJ. Characterization of in vivo salivary-derived enamel pellicle. Arch 
Oral Biol 1989;34(4):289-95. 
26. Fisher SJ, Prakobphol A, Kajisa L, Murray PA. External radiolabelling of components of 
pellicle on human enamel and cementum. Arch Oral Biol 1987;32(7):509-17. 
27. Edgerton M, Lo SE, Scannapieco FA. Experimental salivary pellicles formed on titanium 
surfaces mediate adhesion of streptococci. Int J Oral Maxillofac Implants 1996;11(4):443-9. 
28. Tabak LA, Levine MJ, Mandel ID, Ellison SA. Role of salivary mucins in the protection of the 
oral cavity. J Oral Pathol 1982, Feb;11(1):1-17. 
29. Bruno LS, Li X, Wang L, Soares RV, Siqueira CC, Oppenheim FG, et al. Two-hybrid analysis 
of human salivary mucin MUC7 interactions. Biochim Biophys Acta 2005, Oct 30;1746(1):65-72. 
30. Ganeshnarayan K, Velliyagounder K, Furgang D, Fine DH. Human salivary cystatin SA 
exhibits antimicrobial effect against aggregatibacter actinomycetemcomitans. J Periodontal Res 
2012, Oct;47(5):661-73. 
31. Lamkin MS, Oppenheim FG. Structural features of salivary function. Crit Rev Oral Biol Med 
1993;4(3-4):251-9. 
32. Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, Troxler RF. 
Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, 
characterization, primary structure, and fungistatic effects on candida albicans. J Biol Chem 1988, 
Jun 5;263(16):7472-7. 
  
43 
33. Raj PA, Edgerton M, Levine MJ. Salivary histatin 5: Dependence of sequence, chain length, 
and helical conformation for candidacidal activity. J Biol Chem 1990, Mar 5;265(7):3898-905. 
34. Edgerton M, Koshlukova SE. Salivary histatin 5 and its similarities to the other antimicrobial 
proteins in human saliva. Adv Dent Res 2000, Dec;14:16-21. 
35. Siqueira WL, Margolis HC, Helmerhorst EJ, Mendes FM, Oppenheim FG. Evidence of intact 
histatins in the in vivo acquired enamel pellicle. J Dent Res 2010, Jun;89(6):626-30. 
  
 
 
 
  
  
44 
Chapter 3 
 
“Key aspects for the future work”  
 
 Orthodontic brackets serve as loci for biofilm formation and create new locations for plaque 
retention, which increase dangerously the chances of tooth demineralization (1). In consequence, 
the incidence of white spot lesions was reported to be 60% in orthodontic patients (2). In some 
cases, orthodontic treatment must be interrupted, because of lack of oral hygiene and high 
prevalence of decay in the mouth, causing perfectly straight teeth with compromised oral health. 
If clinicians want to minimize the risk of caries and white spot lesions, it is important to emphasize 
on investigating protein adherence on different orthodontic materials, since proteins are the first 
to adsorb onto the surface of the bracket, saturating completely the surface within seconds to 
minutes. Later, living cells, including bacteria, will contact and interact with the molecular 
structure of the adsorbed protein layer forming the biofilm (3). Effectively, initial bacterial 
attachment is mediated by the protein pellicle composition, which can modify the surface 
chemistry and have an impact on bacterial adhesion (4). Therefore, understanding the modulation 
of the acquired pellicle when the surface of the orthodontic brackets change allows us to have a 
better knowledge on the future biofilm formation.  
 
Our research suggests that the adsorbed protein layer and in consequence the biofilm will be 
different depending on the surface of the material because most of the proteins present on the 
acquired pellicle were identified specifically to each group, indicating little overlap in the acquired 
pellicle proteins. Furthermore, significant differences on the type of proteins responsible of dental 
plaque formation and maturation like amylase (5) were noted between the different types of 
brackets. When the 20 most abundant proteins from each group were analyzed, our results showed 
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that Alpha-amylase was present only on ceramic brackets. Prior studies demonstrated that salivary 
alpha-amylase binds very selectively and with high affinity to several streptococcal species (5). 
This is likely to influences commensal bacterial colonization (6) and to increase the sucrase and 
transferase component activities of S. mutans (7). Furthermore, starch may intensify the adhesion 
of amylase-binding streptococci to amylase in dental pellicles and increase the formation of dental 
plaque (5). This can be related to past literature that suggests that ceramic brackets have more 
affinity for Streptococcus mutants then metallic brackets (8).  
 
Because of the high demand of esthetic brackets, orthodontic materials have improved drastically 
on that area. However, few literature is concentrated on new ceramic and metallic brackets treated 
or coated with material that will decreased white spot lesions and caries. On the other hand, in the 
implantology field we found an evolution on multiple treated surfaces in the past 25 years (9). 
Surface energy, charge, composition and morphology is amongst the physicochemical 
characteristic which were modified during the years for a better stability and biocompatibility of 
the implants (9). It will be interesting in the future to have orthodontic brackets (SS and ceramic) 
coated with materials that absorb proteins able to repulse bacteria responsible for tooth 
demineralization.  
For further control of cariogenic plaque, it will also be interesting to have orthodontic accessories, 
such as powerchains and elastics, with same physical properties but with chemical components 
that help decrease cariogenic biofilm accumulation and maturation. For the moment, research has 
reported a possible coating on the surface of SS orthodontic brackets that released sufficient Silver 
(Ag) ions when immersed in phosphate-buffered saline which shows significant antimicrobial 
potency against Streptococcus mutans and Aggregatibacter actinomycetemcomitans strains (10).  
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Some authors also report fluoride-releasing materials (11,12) to reduce the risk of developing a 
white spot lesions around the orthodontic bracket. However, Nascimento concluded by warning 
orthodontists that there is limited evidence to support the use of fluoride-releasing materials in 
order to prevent white spot lesions development (11).  Furthermore, a review on prevention and 
treatment of white spot lesions mentions that multiple recent narrative and systematic reviews have 
failed to present sufficient evidence for most preventive measures against white spot lesions, 
except for the topical application of fluoride-containing products (13). However, fluoride 
mouthwash and fluoride toothpaste have the disadvantage to be patient-dependant. It has been 
shown that only 13% of the patients comply fully with the fluoride recommendations (14). These 
data highlight the importance of developing modified fluoride-releasing materials instead of 
depending on the “good hygiene” of our patients.  
 
New area of research, including proteomics allows us to study the protein pellicle with precision. 
This new science is very promising to help us understand better the relationship between oral 
biofilm and oral disease with the objective of providing information on potential targets for biofilm 
interruption and advance with new antimicrobial materials.  
 
This study, is very relevant because it opens avenues on the not yet characterized changes on the 
bracket surface and the possible ways to modulate the acquired bracket pellicle in our advantage. 
In a near future, we hope to see new materials able to prevent cariogenic biofilm adhesion, and to 
attract proteins that can promote tooth remineralization to the bracket surface. This will have a big 
impact on the oral health of orthodontic patients.  
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Table 1. Atoms % of molecules on the surface of A) HA Discs; (ND) HA discs without incubation, (DW) HA discs incubated in distilled water, 
B) SS orthodontic brackets; (NB) SS brackets without incubation, (BW) SS bracket incubated in distilled water, C) ceramic brackets; (NCB) C 
brackets without incubation, (CBW) C brackets incubated in distilled water. Means ±SD 
A)     B) 
  
C) 
    
  DW 
 
  BW 
 
  CBW 
   
I 0.1 ±0.0 
 
Ag 10.6 ±0.8 
 
Al 28.3±1.22 
   
Ca 21.4±0.2 
 
B 5.3±0.4 
 
Ca 0.1±0.04 
   
Cu 0.8 ±0.1 
 
Cr 12.8±1.3 
 
Cl 0.1±0.14 
   
F 0.2 ±0.3 
 
Cu 1.6±0.2 
 
F 0.1±0.10 
   
Na 0.5±0.4 
 
Fe 3.4±0.7 
 
K 0.7±0.6 
   
O 62.4 ±0.5 
 
N 5.9±1.1 
 
N 0.8±0.22 
   
P 14.7±0.8 
 
Na 0.7±0.5 
 
Na 0.4±0.18 
   
Ratio Ca/P 1.5±0.1 
 
Nb 1.5±0.2 
 
O 67.2±1.61 
   
   
O 55.0±0.4 
 
S ⎯ 
   
   
Pd 0.9±0.0 
 
Si 2.3±0.32 
   
   
S 1.1±0.3 
      
   
Si 1.2±0.4 
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Table 2.  Total pellicle proteins present on metallic brackets surface (BMQ), ceramic brackets (CBMQ) 
and HA discs (DMQ) 
BMQ 
Accession Number Description (protein name)  
Ion 
count 
score 
MW 
[kDa] 
P13645 Keratin, type I cytoskeletal 10 263.77 58.79 
A0A0A0MTS7 Titin 175.26 3992.17 
H6VRF8 Keratin 1  175.13 66.01 
P02814 Submaxillary gland androgen-regulated protein 3B 105.99 8.18 
P35527 Keratin, type I cytoskeletal 9  96.87 62.03 
P35908 Keratin, type II cytoskeletal 2 epidermal 96.10 65.39 
M0R088 Serine/arginine repetitive matrix protein 1 59.52 78.09 
Q6ZRI6 Uncharacterized protein C15orf39 56.38 110.60 
P15515 Histatin-1 54.31 6.96 
B3KXW2 cDNA FLJ46178 fis, clone TESTI4003944 50.78 141.62 
F5GZK2 Collagen alpha-1(XXI)  49.95 99.23 
Q8WXI7 Mucin-16 47.89 1518.24 
Q96RT6 cTAGE family member 2 41.43 85.23 
B4DRU6 
cDNA FLJ54657, highly similar to Keratin, type II 
cytoskeletal 6A 
39.88 58.50 
Q92954 Proteoglycan 4 39.63 150.98 
Q5CZC0 Fibrous sheath-interacting protein 2 34.44 780.12 
B4DVQ0 cDNA FLJ58286, highly similar to Actin, cytoplasmic 2 33.09 37.32 
A0A0J9YYJ7 Unconventional myosin-XVB  32.86 79.47 
A2A2V2 RNA-binding protein 34 32.18 45.89 
B3KNX8 cDNA FLJ30689 fis, clone FCBBF2000566 30.34 84.45 
E9PAV3 
Nascent polypeptide-associated complex subunit alpha, 
muscle-specific form 
30.12 205.29 
Q7Z5P9 Mucin-19 30.11 804.77 
Q6P4R9 SASH1 protein 25.96 134.74 
Q01546 Keratin, type II cytoskeletal 2 oral  25.07 65.80 
Q9C0F0 Putative Polycomb group protein ASXL3  22.60 241.77 
P02808 Statherin  22.41 7.30 
O60382 KIAA0324  22.20 191.19 
A0A0U1RRH1 Ryanodine receptor 3  20.06 550.47 
Q3SY84 Keratin, type II cytoskeletal 71 19.15 57.26 
Q5T3J3 Ligand-dependent nuclear receptor-interacting factor 1  17.82 84.52 
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A8K781 cDNA FLJ75299 17.80 47.29 
T1R7N3 MUC5AC  16.90 413.62 
Q5VST9 Obscurin  16.86 867.94 
Q5SYE7 NHS-like protein 1  16.58 170.56 
A0A024RBF1 
Protein phosphatase 1, regulatory (Inhibitor) subunit 12A, 
isoform CRA_a 
16.55 101.54 
A4UGR9 Xin actin-binding repeat-containing protein 2  16.29 382.06 
Q86UP3 Zinc finger homeobox protein 4  16.13 393.48 
H7BY37 Histone-lysine N-methyltransferase 2C  16.09 269.44 
Q2KHM5 CENPJ protein  16.02 129.87 
G8GEI5 Coagulation factor VIII  15.77 8.36 
B7ZA42 cDNA, FLJ79056  15.51 77.19 
Q9NSI6 Bromodomain and WD repeat-containing protein 1  15.39 262.77 
Q9ULU4 Protein kinase C-binding protein 1 15.27 131.61 
K7ERE3 Keratin, type I cytoskeletal 13 15.18 45.23 
C9JE98 Nuclear receptor corepressor 2  15.05 267.88 
Q86YZ3 Hornerin  14.75 282.23 
A0A0B4J1Z0 COBL-like 1, isoform CRA_a  14.40 46.75 
A0A087WZ32 Pleckstrin homology domain-containing family A member 2  14.39 41.18 
B8XCX8 EPC1/ASXL2b fusion protein  13.90 201.73 
B4DDN6 cDNA FLJ54422 13.75 71.96 
E9PPJ1 Kinetochore scaffold 1 13.69 195.52 
Q9UJT9 F-box/LRR-repeat protein 7  13.55 54.54 
A0A1U9XBF2 MDC1  13.35 226.47 
B4E1A2 
Gamma-aminobutyric acid (GABA) A receptor, alpha 5, 
isoform CRA_a  
13.31 38.99 
P54259 Atrophin-1  13.22 125.34 
Q8WXG9 G-protein coupled receptor 98  13.19 692.64 
B4DH81 cDNA FLJ61250 13.18 93.45 
Q96HA1 Nuclear envelope pore membrane protein POM 121  13.17 127.64 
P51826 AF4/FMR2 family member 3  13.15 133.39 
A0A1U9XBE1 MDC1  13.06 226.46 
A0A1B0GWE0 Dedicator of cytokinesis protein 7 (Fragment)  13.05 139.52 
Q66PJ3 ADP-ribosylation factor-like protein 6-interacting protein 4  12.93 44.89 
Q15751 Probable E3 ubiquitin-protein ligase HERC1  12.90 531.89 
Q9NXV6 CDKN2A-interacting protein  12.83 61.09 
Q8N7X4 Melanoma-associated antigen B6  12.62 43.96 
A0A087WW76 Rho GTPase-activating protein 21  12.42 155.89 
B5M450 Anion exchange protein  12.40 135.22 
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Q8IVL0 Neuron navigator 3  12.32 255.49 
Q6LEQ8 LTG9/MLLT3 protein 11.59 38.09 
Q96T58 Msx2-interacting protein  11.45 402.00 
Q6ZU65 Ubinuclein-2 11.33 146.00 
J3KQ96 Treacle protein  11.25 144.04 
Q6PII6 TMF1 protein  11.25 58.35 
A0A1U9X7B3 BRD2  11.21 74.71 
Q7Z7G8 Vacuolar protein sorting-associated protein 13B  11.11 448.38 
O75592 E3 ubiquitin-protein ligase MYCBP2  11.08 509.76 
B2RAG9 Mediator of RNA polymerase II transcription subunit 1  11.08 166.54 
Q9UPN3 Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 11.06 837.79 
Q5KU20 G-protein coupled receptor  11.05 102.05 
Q6N055 Putative uncharacterized protein DKFZp686O11112 11.03 35.54 
H3BM45 
Ankyrin repeat and fibronectin type-III domain-containing 
protein 1  
10.87 129.87 
Q59H94 Gamma filamin variant  10.69 142.73 
F4MH51 
Ubiquitously transcribed tetratricopeptide repeat protein Y-
linked transcript variant 60 
10.41 147.07 
D6RD46 LIM and calponin homology domains-containing protein 1 10.35 109.87 
B7Z2P9 E3 ubiquitin-protein ligase  10.34 96.34 
A0A1W2PR28 IQ motif and SEC7 domain-containing protein 2 10.31 127.90 
Q96JG9 Zinc finger protein 469  10.29 409.95 
Q9BTM2 C2CD2L protein 10.17 28.22 
Q9NZR2 Low-density lipoprotein receptor-related protein 1B  10.17 515.16 
O95996 Adenomatous polyposis coli protein 2 10.09 243.80 
B4DJT3 cDNA FLJ54498, weakly similar to Mucin-like protein 1  10.04 67.74 
A0A024RAN2 Calpastatin, isoform CRA_a  10.03 86.56 
B7ZLW1 CAMSAP1 protein 10.01 163.16 
Q5T4S7 E3 ubiquitin-protein ligase UBR4  9.99 573.48 
F8VZ81 TBC1 domain family member 30  9.99 71.78 
X6R7H2 
Peroxisome proliferator-activated receptor gamma 
coactivator-related protein 1 
9.98 69.06 
Q53F67 
Kringle-containing transmembrane protein 2 isoform b 
variant  
9.96 44.42 
Q6ZS56 cDNA FLJ45819 fis, clone NT2RP8001363 9.96 66.96 
Q96F05 Uncharacterized protein C11orf24  9.93 46.07 
Q8IVF2 Protein AHNAK2  9.91 616.24 
A0A087WXN9 MTSS1-like protein  9.90 79.75 
Q9UL49 Transcription factor-like 5 protein  9.89 52.66 
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H0YLN8 
Transient receptor potential cation channel subfamily M 
member 7 
9.87 212.49 
B3KPL9 cDNA FLJ31930 fis, clone NT2RP7006162 9.85 47.82 
A0A0G2JN73 Diffuse panbronchiolitis critical region protein 1 9.84 56.31 
Q05CT8 NEDD1 protein 9.83 57.47 
A0A1B0GUS7 Protein unc-13 homolog B 9.79 483.83 
Q9NR48 Histone-lysine N-methyltransferase ASH1L 9.76 332.58 
Q53QN9 Putative uncharacterized protein ABCG5 9.76 60.84 
A0A1B0GV45 Unconventional myosin-XVIIIa 9.74 49.69 
I0B0K8 Truncated profilaggrin 9.72 430.16 
B7Z526 cDNA FLJ59292 9.71 85.62 
H7C1L9 E3 ubiquitin-protein ligase TRIP12  9.69 22.41 
Q59G99 Dishevelled 1 isoform a variant  9.69 40.28 
E7EPM4 Mucin-17 9.64 425.29 
H3BR17 E3 ubiquitin-protein ligase TRAF7  9.63 15.86 
B4E392 cDNA FLJ52602, highly similar to Pinin 9.63 49.11 
Q9UHR4 
Brain-specific angiogenesis inhibitor 1-associated protein 2-
like protein 1 
9.63 56.85 
Q92610 Zinc finger protein 592  9.62 137.44 
A0A1W2PQJ7 Retinoic acid-induced protein 1  9.54 183.82 
P46013 Proliferation marker protein Ki-67 9.54 358.47 
K7EMR9 Dynamin-2  9.53 18.20 
Q9HCK8 Chromodomain-helicase-DNA-binding protein 8  9.52 290.34 
F5H101 Nucleolar protein 8  9.48 121.52 
P56555 Down syndrome critical region protein 4  9.37 12.95 
Q8NA90 cDNA FLJ35733 fis, clone TESTI2003277 9.36 29.45 
A8KAI3 cDNA FLJ77394 9.09 57.44 
H3BLS7 Vacuolar protein sorting-associated protein 13D  8.99 356.81 
A0A024QZW7 Nucleoporin 153kDa, isoform CRA_a 8.92 153.87 
B3KR92 cDNA FLJ33882 fis, clone CTONG2007175 8.84 61.73 
A8K8M7 cDNA FLJ76439 8.82 53.73 
Q5VWG9 Transcription initiation factor TFIID subunit 3  8.76 103.52 
Q14686 Nuclear receptor coactivator 6 8.73 219.01 
A0A1W2PQW2 
Voltage-dependent T-type calcium channel subunit alpha-
1H 
8.59 178.43 
Q9UPU5 Ubiquitin carboxyl-terminal hydrolase 24  8.53 294.18 
P13611 Versican core protein  8.46 372.59 
P25054 Adenomatous polyposis coli protein 8.36 311.45 
Q02388 Collagen alpha-1(VII)  8.32 295.04 
A0A0A0MS79 Nck-associated protein 5  8.26 208.35 
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Q9UIF8 Bromodomain adjacent to zinc finger domain protein 2B  8.26 240.31 
A0A140VJJ5 Testicular tissue protein Li 69  8.13 119.70 
Q8WVS4 WD repeat-containing protein 60  8.07 122.50 
A0A0U1RQK4 [Protein ADP-ribosylarginine] hydrolase-like protein 1  7.97 211.69 
Q8NB66 Protein unc-13 homolog C  7.86 250.75 
Q7Z2Y8 Interferon-induced very large GTPase 1  7.83 278.87 
F8WDA1 5'-AMP-activated protein kinase subunit gamma-2  7.80 24.62 
B5A965 Soluble FGFR4 variant 2  7.48 48.62 
H7BY35 Ryanodine receptor 2  7.37 562.25 
Q9UKN1 Mucin-12  7.25 557.83 
A0A1S5UZ29 Kalirin  7.24 269.17 
H0YL16 Serine/threonine-protein kinase PAK 6  7.21 30.72 
Q86XZ4 Spermatogenesis-associated serine-rich protein 2  7.20 59.51 
Q5T0Z8 Uncharacterized protein C6orf132  7.18 123.96 
A8K8U1 cDNA FLJ77762 7.17 136.23 
Q9NYB5 Solute carrier organic anion transporter family member 1C1 7.15 78.65 
D3DWL9 
Cleavage and polyadenylation specific factor 1, 160kDa, 
isoform CRA_a 
7.11 151.89 
Q9NT22 EMILIN-3  7.08 82.60 
B1WB49 BDP1 protein 7.04 293.25 
Q6WKZ4 Rab11 family-interacting protein 1 6.96 137.08 
Q8WYX4 Putative uncharacterized protein pp11662  6.94 21.03 
P49916 DNA ligase 3  6.94 112.83 
O60307 Microtubule-associated serine/threonine-protein kinase 3  6.93 143.05 
E9PL24 Myomegalin  6.88 126.87 
H7BZB4 C2 domain-containing protein 3  6.88 86.23 
B4E345 cDNA FLJ50374, weakly similar to Protein groucho 6.86 61.71 
Q9UF83 Uncharacterized protein DKFZp434B061  6.86 59.38 
D3DR86 
Nuclear factor of kappa light polypeptide gene enhancer in 
B-cells 2 (P49/p100) 
6.84 44.23 
Q5M9Q1 NKAP-like protein  6.83 46.28 
Q9Y5S2 Serine/threonine-protein kinase MRCK beta  6.83 194.19 
A2SY06 MAP/microtubule affinity-regulating kinase 3 6.81 36.68 
Q9NRK6 
ATP-binding cassette sub-family B member 10, 
mitochondrial 
6.80 79.10 
P98169 Zinc finger X-linked protein ZXDB  6.80 84.74 
A0A075B6G6 Filamin A interacting protein 1, isoform CRA_c  6.80 127.13 
Q9HCM3 UPF0606 protein KIAA1549  6.80 210.63 
Q969K3 E3 ubiquitin-protein ligase RNF34 6.80 41.61 
H0YC33 La-related protein 1 6.79 20.88 
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B9ZVN9 DNA-directed RNA polymerase subunit 6.78 187.69 
A8KAY2 Fibrillin 3  6.76 300.12 
B4E223 cDNA FLJ52075 6.76 68.46 
Q6ZMZ1 cDNA FLJ16568 fis, clone TESOP2000390 6.74 52.00 
C9J164 
Ras-associated and pleckstrin homology domains-containing 
protein 1  
6.72 67.14 
A0A024R7D8 
Ral guanine nucleotide dissociation stimulator-like 3, 
isoform CRA_a  
6.72 51.08 
Q8NAV8 cDNA FLJ34691 fis, clone MESAN2000909 6.72 64.30 
B4DGV8 cDNA FLJ54286 6.71 19.45 
H7C189 Ubiquitin carboxyl-terminal hydrolase 4  6.70 69.51 
Q8N0Z3 Spindle and centriole-associated protein 1  6.69 96.21 
Q9UJ55 MAGE-like protein 2  6.69 132.74 
Q96KW2 POM121-like protein 2  6.69 109.84 
Q5T1H1 Protein eyes shut homolog 6.68 350.57 
A8MXZ3 Keratin-associated protein 9-1  6.68 26.31 
Q6DKI7 Transmembrane protein PVRIG 6.68 34.32 
P47989 Xanthine dehydrogenase/oxidase  6.67 146.33 
B2RTX2 Palladin, cytoskeletal associated protein  6.67 121.97 
A0A0A0MS59 Helicase SRCAP  6.66 315.42 
A0A090N8E5 
Similar to OG-2 homeodomain protein-like similar to 
U65067 (PID:g1575526)  
6.65 52.71 
Q0IIP3 C20orf194 protein  6.65 102.18 
A0A024RAL3 Zinc finger, FYVE domain containing 16, isoform CRA_a  6.65 168.74 
M0R219 Liprin-alpha-4 6.64 20.44 
Q53TT7 Putative uncharacterized protein ALS2CR3  6.63 97.93 
L8E9Z3 Alternative protein HRC 6.62 34.32 
O43149 
Zinc finger ZZ-type and EF-hand domain-containing protein 
1  
6.62 330.86 
Q6ZWP8 Inactive rhomboid protein 6.62 80.36 
M0R0C4 Dystrobrevin alpha  6.60 18.64 
A0A5B4 T-cell receptor beta variable 20-1  6.60 12.20 
V9GZ26 Protein FAM110A 6.60 19.68 
M0R0F4 Atypical kinase COQ8B, mitochondrial  6.60 12.11 
J3QKX6 
SWI/SNF-related matrix-associated actin-dependent 
regulator of chromatin subfamily E member 1  
6.60 14.60 
P35900 Keratin, type I cytoskeletal 20 6.59 48.46 
A0A1S5UYZ7 Rap guanine nucleotide exchange factor 1 6.56 120.16 
Q13233 Mitogen-activated protein kinase kinase kinase 1  6.56 164.37 
Q8IYJ2 Uncharacterized protein C10orf67, mitochondrial 6.55 63.62 
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B2RB68 cDNA, FLJ95336 6.55 67.80 
B4DQR1 cDNA FLJ55241 6.55 22.93 
Q4EW05 Rhesus blood group D antigen 6.55 6.03 
B4DLJ7 cDNA FLJ59334 6.54 57.18 
A0A087WUH9 Serine/threonine-protein kinase PLK  6.53 76.60 
Q9ULL0 Acrosomal protein KIAA1210  6.52 186.90 
B3KVV3 cDNA FLJ41584 fis, clone CTONG2020445 6.52 72.29 
E9PCY0 Dynactin subunit 1  6.52 19.44 
Q9Y4F1 FERM, RhoGEF and pleckstrin domain-containing protein 1  6.52 118.56 
A0A024R2Y4 Bassoon (Presynaptic cytomatrix protein), isoform CRA_a  6.52 416.24 
Q86YS7 C2 domain-containing protein 5 6.50 110.38 
D3DPE6 
Wiskott-Aldrich syndrome protein interacting protein, 
isoform CRA_a  
6.49 50.27 
O60293 Zinc finger C3H1 domain-containing protein  6.48 226.21 
H3BN61 Doublesex- and mab-3-related transcription factor 1  6.48 23.16 
P39880 Homeobox protein cut-like 1  6.47 164.09 
J3KSW8 Myosin phosphatase Rho-interacting protein  6.45 95.87 
H0Y797 Thyrotroph embryonic factor  6.45 20.00 
A5XEH6 WNK lysine deficient protein kinase 1  6.44 7.71 
E9PM59 
TATA box-binding protein-associated factor RNA 
polymerase I subunit D  
6.44 25.03 
H0YEU1 CD44 antigen  6.43 27.26 
C9JR56 DNA-binding protein SATB  6.43 75.99 
H0YGW3 Protein FAM13C  6.43 15.38 
Q96RV3 Pecanex-like protein 1  6.43 258.51 
Q4KWH8 
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase 
eta-1  
6.43 189.10 
J3KNV1 Zinc finger protein 292  6.43 304.02 
L8E767 Alternative protein RNF222  6.42 19.45 
F5GX59 Zonadhesin  6.41 282.23 
F5H514 RAS guanyl-releasing protein 1  6.41 90.31 
O75113 NEDD4-binding protein 1  6.40 100.32 
C9JFF0 Kinesin-like protein KIF26A  6.40 180.04 
Q59FH1 
Transformation/transcription domain-associated protein 
variant  
6.39 405.56 
H0Y8C9 ATP-binding cassette sub-family A member 2 6.38 118.05 
A0A087WYF1 Laminin subunit alpha-2  6.38 343.20 
A9UF07 BCR/ABL fusion protein isoform Y5 6.37 196.45 
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B4DHI4 
cDNA FLJ60536, highly similar to Death-associated protein 
kinase 1 (EC 2.7.11.1) OS=Homo sapiens PE=2 SV=1 - 
[B4DHI4_HUMAN] 
6.36 159.96 
D3DSU3 Kinesin family member 13B, isoform CRA_a  6.36 174.69 
F5H3X8 Poly [ADP-ribose] polymerase 6.36 55.11 
Q53F19 Nuclear cap-binding protein subunit 3  6.35 70.55 
Q6R743 MHC class I antigen 6.34 41.60 
P98088 Mucin-5AC  6.34 585.20 
Q7LGH1 KIAA0480 protein  6.32 146.90 
B5BUB1 RuvB-like helicase  6.31 50.18 
Q9NX53 Exonuclease mut-7 homolog, isoform 5  6.29 26.34 
Q59F85 Glucose phosphate isomerase variant  6.28 55.65 
Q53GZ4 Leucine rich repeat containing 5 variant  6.26 76.80 
P61129 Zinc finger CCCH domain-containing protein 6  6.26 131.59 
B4E1I2 
cDNA FLJ61037, highly similar to Intraflagellar transport 
88 homolog  
6.26 12.38 
Q8N3N3 Putative uncharacterized protein DKFZp762L056  6.26 89.64 
Q59EC9 Glyceronephosphate O-acyltransferase variant  6.25 78.54 
L8ECB8 Alternative protein NR5A1  6.25 19.48 
Q9C0D2 Centrosomal protein of 295 kDa 6.22 295.00 
Q0PNF2 FEX1 6.14 275.27 
A6NCG2 Solute carrier family 22 member 11  6.13 52.58 
D6RGF0 Protein Largen 6.12 15.22 
B0I1S4 DNHD1 variant protein  6.08 428.42 
Q8IWQ8 SCAMPER  6.07 12.41 
Q5TIG5 Afadin  6.05 189.04 
Q05BX6 RABEP1 protein  6.04 82.33 
Q8N3K9 Cardiomyopathy-associated protein 5  6.02 448.94 
A0A024RDF7 Uncharacterized protein 5.99 130.17 
O00757 Fructose-1,6-bisphosphatase isozyme 2  5.98 36.72 
H0YC63 Microtubule-associated tumor suppressor 1 5.94 55.14 
I3L3K8 Sodium-independent sulfate anion transporter 5.89 7.91 
Q9HBD1 Roquin-2  5.88 131.59 
B3KUX0 cDNA FLJ40831 fis, clone TRACH2012138 5.88 35.87 
Q5JR59 Microtubule-associated tumor suppressor candidate 2  5.84 150.10 
P26378 ELAV-like protein 4  5.84 41.74 
C1KEQ3 GLCCI1  5.80 3.59 
B2RWP0 Signal-induced proliferation-associated 1 like 3 5.80 194.50 
A0A0A0MRJ3 Neuron navigator 1  5.80 197.28 
Q8IXV0 HES1 protein  5.79 29.25 
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A1L0S8 CROCC protein  5.79 129.39 
Q5T1R4 Transcription factor HIVEP3 5.75 259.30 
B2RE19 cDNA, FLJ96877  5.75 70.92 
B4DSW4 
cDNA FLJ51541, moderately similar to Transcription factor 
Sp8  
5.69 16.42 
Q6ZMY0 
cDNA FLJ16598 fis, clone TESTI4006473, weakly similar 
to ATP-dependent RNA helicase A  
5.67 150.88 
C9JMI8 TBC1 domain family member 25  5.65 24.95 
Q6UWX4 HHIP-like protein 2  5.02 80.73 
A4PB67 YY1AP-related protein1  4.98 248.19 
E9PG32 Dynein heavy chain 12, axonemal  4.97 454.03 
Q6ZSX8 cDNA FLJ45139 fis, clone BRAWH3039623  4.92 15.46 
O15078 Centrosomal protein of 290 kDa 4.91 290.21 
Q8NDM7 Cilia- and flagella-associated protein 43 4.86 191.86 
Q8N1H6 cDNA FLJ40869 fis, clone TSTOM2000139  4.79 53.78 
O15014 Zinc finger protein 609  4.78 151.10 
Q5TAX3 Terminal uridylyltransferase 4 4.31 185.05 
B7Z7H2 
cDNA FLJ58079, highly similar to Homo sapiens SH3 
multiple domains 1 (SH3MD1), mRNA 
4.04 106.32 
CBMQ 
Accession Number Description (protein name)  
Ion 
count 
score 
MW 
[kDa] 
P04745 Alpha-amylase 1  606.56 57.73 
F6KPG5 Albumin  166.66 66.49 
P02814 Submaxillary gland androgen-regulated protein 3B  165.02 8.18 
P06702 Protein S100-A9  160.46 13.23 
Q6PJF2 IGK@ protein  137.04 25.50 
C0JYZ2 Titin 129.49 3711.40 
P01833 Polymeric immunoglobulin receptor  121.67 83.23 
P01036 Cystatin-S  116.55 16.20 
P01037 Cystatin-SN  95.10 16.38 
A0A0C4DGN4 Zymogen granule protein 16 homolog B 88.79 19.59 
P23280 Carbonic anhydrase 6 88.59 35.34 
P25311 Zinc-alpha-2-glycoprotein  86.75 34.24 
H6VRF8 Keratin 1 79.25 66.01 
P12273 Prolactin-inducible protein  68.47 16.56 
Q8WXI7 Mucin-16  60.58 1518.24 
P0DOX7 Immunoglobulin kappa light chain  59.06 23.36 
P05109 Protein S100-A8  56.20 10.83 
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P06733 Alpha-enolase  54.12 47.14 
P01876 Immunoglobulin heavy constant alpha 1 50.62 37.63 
E7ER44 Lactotransferrin 50.07 77.92 
F5GZK2 Collagen alpha-1(XXI) chain 49.95 99.23 
A0M8Q6 Immunoglobulin lambda constant 7  45.56 11.25 
P04080 Cystatin-B  44.73 11.13 
B4DW52 cDNA FLJ55253, highly similar to Actin, cytoplasmic 1 43.69 38.61 
P13645 Keratin, type I cytoskeletal 10  41.19 58.79 
B1AN48 Small proline-rich protein 3  39.34 16.95 
P28325 Cystatin-D  38.76 16.07 
A0A0A0MQW7 
Leukocyte immunoglobulin-like receptor subfamily B 
member 4 
38.27 14.44 
Q0QET7 Glyceraldehyde-3-phosphate dehydrogenase  37.96 24.60 
J3KNQ2 Fibronectin type III domain-containing protein 1  36.62 194.42 
K7ESB7 Dedicator of cytokinesis protein 6  34.95 148.70 
Q92954 Proteoglycan 4 33.41 150.98 
G3V1A4 Cofilin 1 (Non-muscle), isoform CRA_a  33.14 16.80 
E9PCT1 Serine/arginine repetitive matrix protein 1  25.61 93.38 
A8K781 
cDNA FLJ75299, highly similar to Xenopus laevis 
proteasome (prosome, macropain) 26S subunit, ATPase 3, 
mRNA  
22.25 47.29 
P31025 Lipocalin-1  21.55 19.24 
Q7Z351 Putative uncharacterized protein DKFZp686N02209 20.15 52.82 
V9HWC6 Peptidyl-prolyl cis-trans isomerase  19.72 22.73 
Q1RMC9 ERBB2IP protein  19.23 153.42 
A8K2I0 
cDNA FLJ78504, highly similar to Homo sapiens keratin 
6A (KRT6A), mRNA 
18.91 59.99 
A0A0J9YYJ7 Unconventional myosin-XVB  18.26 79.47 
Q8WXG9 G-protein coupled receptor 98  17.79 692.64 
B7Z830 cDNA FLJ61741, highly similar to HIRA protein  17.13 63.97 
A0A087X1X8 Uncharacterized protein 17.12 21.74 
B4E1B2 cDNA FLJ53691, highly similar to Serotransferrin 16.95 74.78 
H7C517 Adenylate kinase 9  16.94 87.28 
A0A087WW06 Tetratricopeptide repeat protein 28  16.70 256.71 
C9JFF0 Kinesin-like protein KIF26A  16.48 180.04 
Q59FL8 Receptor protein-tyrosine kinase  16.08 119.87 
I0B0K8 Truncated profilaggrin  15.94 430.16 
Q7Z5P9 Mucin-19  15.85 804.77 
Q8WYP5 Protein ELYS  15.45 252.34 
E1A689 Mutant Apo B 100 15.11 489.51 
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A0A0G2JRN3 Alpha-1-antitrypsin  14.72 40.21 
E9PAV3 
Nascent polypeptide-associated complex subunit alpha, 
muscle-specific for 
14.61 205.29 
P35527 Keratin, type I cytoskeletal 9  14.55 62.03 
Q8TEA3 
cDNA FLJ23738 fis, clone HEP15081, highly similar to 
PDZ domain-containing guanine nucleotide exchange 
factor I  
14.54 126.03 
B4E223 
cDNA FLJ52075, moderately similar to Mus musculus 
SPT2, Suppressor of Ty, domain containing 1, mRNA 
14.21 68.46 
Q8N4F0 BPI fold-containing family B member 2  14.16 49.14 
P49639 Homeobox protein Hox-A1  14.01 36.62 
E7EVA0 Microtubule-associated protein  13.84 245.29 
H9KV90 SH3 and multiple ankyrin repeat domains protein 1  13.51 225.76 
T1S9D5 MUC5AC 13.45 521.30 
Q8IVF2 Protein AHNAK2  13.23 616.24 
Q86Y00 GTF2IRD2B protein  13.16 50.83 
P10599 Thioredoxin  12.98 11.73 
B7Z8H1 cDNA FLJ54814  12.92 24.15 
B3KX86 cDNA FLJ44973 fis, clone BRAWH3001638 12.84 125.22 
B2RNR6 Zinc finger RNA binding protein  12.52 116.94 
B7ZLW1 CAMSAP1 protein  11.83 163.16 
O15083 ERC protein 2 11.73 110.49 
K7EJ44 Profilin  11.55 11.38 
Q5CZC0 Fibrous sheath-interacting protein 2  11.49 780.12 
Q5TAX3 Terminal uridylyltransferase 4  11.41 185.05 
Q12830 Nucleosome-remodeling factor subunit BPTF  11.22 338.05 
J3KPS2 Protein FAM83H  11.03 96.39 
Q10571 Transcriptional activator MN1 10.98 135.92 
H0Y9N7 Inhibitor of Bruton tyrosine kinase  10.90 14.09 
Q5JPC9 
ABI gene family, member 3 (NESH) binding protein, 
isoform CRA_d  
10.38 110.61 
H3BTR6 RNA-binding protein with serine-rich domain 1 10.27 12.99 
A0A024QZH6 
Serine arginine-rich pre-mRNA splicing factor SR-A1, 
isoform CRA_a 
10.05 139.18 
A4FUT8 JMJD1B protein  10.00 168.95 
K7EL96 Perilipin-3  9.98 17.95 
Q8TD20 
Solute carrier family 2, facilitated glucose transporter 
member 12  
9.93 66.92 
A0A0G2JQF2 Formimidoyltransferase-cyclodeaminase 9.93 45.46 
P54687 Branched-chain-amino-acid aminotransferase, cytosolic  9.86 42.94 
B4DIS5 cDNA FLJ50076, highly similar to Liprin-alpha-4 9.84 103.07 
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Q9NR48 Histone-lysine N-methyltransferase ASH1L  9.81 332.58 
P04275 von Willebrand factor  9.77 309.06 
B4DUY9 cDNA FLJ56362  9.64 67.89 
B4DHH1 
cDNA FLJ57930, highly similar to Homo sapiens RAS 
guanyl releasing protein 1 (calcium and DAG-regulated) 
(RASGRP1), mRNA  
9.42 85.17 
A0A0C4DGV9 DNA ligase  9.19 96.15 
B3KR01 cDNA FLJ33378 fis, clone BRACE2006354 8.90 46.07 
J7M2B1 Tyrosine-protein kinase receptor  8.43 98.89 
P25391 Laminin subunit alpha-1  8.36 336.87 
Q5VST9 Obscurin  8.33 867.94 
Q96L91 E1A-binding protein p400  8.04 343.28 
Q8WXE0 Caskin-2  8.03 126.71 
Q5T112 tRNA (adenine(37)-N6)-methyltransferase 7.96 17.35 
A4PB67 YY1AP-related protein1  7.72 248.19 
P80511 Protein S100-A12  7.56 10.57 
Q6ZQQ6 WD repeat-containing protein 87 7.54 332.97 
U3KPZ7 Uncharacterized protein  7.54 114.47 
A7MBM6 MLL3 protein  7.40 362.42 
A0A0A0MRS7 Ankyrin repeat and SAM domain-containing protein 6  7.10 62.27 
J3KRI5 Cadherin-8 7.06 82.70 
J3KQ96 Treacle protein  7.04 144.04 
B2RMV2 CYTSA protein 6.98 124.50 
D6RHX1 Mucin-7  6.94 15.45 
B4E1M1 cDNA FLJ60391 6.86 73.88 
F5GX59 Zonadhesin  6.84 282.23 
H0Y6B5 Abl interactor 2  6.83 31.86 
Q9Y608 Leucine-rich repeat flightless-interacting protein 2 6.82 82.12 
E9PIQ4 Mth938 domain-containing protein 6.82 9.98 
E9PPH6 Exophilin-5  6.77 192.96 
Q9Y4D8 Probable E3 ubiquitin-protein ligase HECTD4 6.75 439.07 
Q4G0P3 Hydrocephalus-inducing protein homolog  6.69 575.53 
E5RIQ7 Eyes absent homolog  6.63 23.33 
Q16880 2-hydroxyacylsphingosine 1-beta-galactosyltransferase  6.63 61.40 
E9PCK9 Muscular LMNA-interacting protein  6.62 59.08 
Q9P0X4 
Voltage-dependent T-type calcium channel subunit alpha-
1I 
6.61 244.95 
K7N7B3 Synaptonemal complex protein 2-like  6.59 93.44 
Q6ZP01 RNA-binding protein 44 6.53 117.91 
Q09666 Neuroblast differentiation-associated protein AHNAK  6.51 628.70 
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B3KY59 
cDNA FLJ46903 fis, clone MESAN2003661, highly 
similar to Cdc42 effector protein 3 (Binder of Rho 
GTPases 2)  
6.50 27.63 
A8K5B3 
cDNA FLJ76829, highly similar to Homo sapiens 
piggyBac transposable element derived 1 (PGBD1), 
mRNA 
6.46 92.39 
Q9BXW9 Fanconi anemia group D2 protein 6.44 164.02 
H9NIL3 G protein-coupled receptor 20 6.42 38.64 
G3V207 
Transmembrane and coiled-coil domain family 3, isoform 
CRA_c 
6.35 50.14 
B4E2E5 
cDNA FLJ56289, highly similar to Homo sapiens sperm 
specific antigen 2 (SSFA2), mRNA  
6.34 119.13 
Q96N67 Dedicator of cytokinesis protein 7 6.31 242.41 
E9PNY3 
Serine/threonine-protein phosphatase 2A 56 kDa 
regulatory subunit beta isoform  
6.31 21.89 
H0Y5R1 
Aryl hydrocarbon receptor nuclear translocator-like protein 
2  
6.30 65.63 
A0A0A0MQR4 Protein capicua homolog  6.29 163.58 
Q9NTI5 Sister chromatid cohesion protein PDS5 homolog B  6.17 164.56 
Q96BY6 Dedicator of cytokinesis protein 10 6.10 249.37 
A0A140VJG7 
Component of oligomeric golgi complex 6, isoform 
CRA_a  
5.88 68.37 
Q9NPV6 Putative uncharacterized protein DKFZp762E1511  5.86 17.77 
Q8N8K9 Uncharacterized protein KIAA1958  5.75 79.16 
J3QT10 N-lysine methyltransferase SETD6 5.67 45.57 
Q9C0G0 Zinc finger protein 407  5.47 247.21 
A0A0A0MRY1 Structural maintenance of chromosomes protein 6 5.27 50.91 
D6RG39 OCIA domain-containing protein 1  5.01 19.01 
Q96RW7 Hemicentin-1  4.98 613.00 
A7MD03 CCDC132 protein  4.98 110.28 
Q8WVS4 WD repeat-containing protein 60  4.93 122.50 
Q96HA1 Nuclear envelope pore membrane protein POM 121  4.86 127.64 
H0Y4R5 Transmembrane protein 201  4.82 59.80 
Q8NB66 Protein unc-13 homolog C  4.78 250.75 
H0Y4C5 NGFI-A-binding protein 1  4.75 27.75 
Q59GI4 Zinc finger, FYVE domain containing 9 isoform 3 variant 4.69 145.96 
E7EX73 Eukaryotic translation initiation factor 4 gamma 1  4.63 158.55 
Q9BTC0 Death-inducer obliterator 1  4.31 243.72 
A6NNC1 Putative POM121-like protein 1-like 4.14 94.00 
DMQ 
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Accession Number Description (protein name)  
Ion 
count 
score 
MW 
[kDa] 
Q8WXI7 Mucin-16  82.02 1518.2 
P15515 Histatin-1  68.85 7.0 
B7ZMD7 Alpha-amylase  66.23 57.7 
D3DPG0 Titin, isoform CRA_a 65.09 3878.8 
P02814 Submaxillary gland androgen-regulated protein 3B  61.25 8.2 
Q7Z5P9 Mucin-19  50.38 804.8 
B3KY63 cDNA FLJ16830 fis, clone UTERU3022536 43.22 215.1 
F5GZK2 Collagen alpha-1(XXI) chain  37.05 99.2 
P01036 Cystatin-S 33.12 16.2 
A0A0U1RR20 Proteoglycan 4  30.51 146.4 
Q86VQ1 Glucocorticoid-induced transcript 1 protein  29.92 58.0 
E9PAV3 
Nascent polypeptide-associated complex subunit alpha, 
muscle-specific form  
24.97 205.3 
Q5VST9 Obscurin  22.78 867.9 
H0Y465 Neurofibromin  20.65 281.0 
T1S9D5 MUC5AC  20.41 521.3 
T1R7N3 MUC5AC  20.12 413.6 
B4DH81 cDNA FLJ61250 19.95 93.5 
B3KY54 cDNA FLJ46886 fis, clone UTERU3016308 19.84 61.6 
Q5SYE7 NHS-like protein 1  19.49 170.6 
Q9UQ35 Serine/arginine repetitive matrix protein 2  19.23 299.4 
A7E2D6 NAV2 protein  18.74 261.6 
F8W9J4 Dystonin  18.06 847.4 
Q96Q06 Perilipin-4  18.01 134.3 
J3KNQ2 Fibronectin type III domain-containing protein 1 17.88 194.4 
Q15648 Mediator of RNA polymerase II transcription subunit 1  17.29 168.4 
Q8N500 Putative uncharacterized protein  16.87 36.0 
Q8IWQ1 TGS2 16.82 60.0 
Q5T4S7 E3 ubiquitin-protein ligase UBR4 16.60 573.5 
Q8IVF2 Protein AHNAK2  16.59 616.2 
Q5VUA4 Zinc finger protein 318  16.47 251.0 
I6L894 Ankyrin-2 16.31 430.0 
Q03164 Histone-lysine N-methyltransferase 2A  16.13 431.5 
Q13136 Liprin-alpha-1 15.76 135.7 
Q8IVL0 Neuron navigator 3  15.67 255.5 
B7ZA42 cDNA, FLJ79056  15.57 77.2 
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Q96HP0 Dedicator of cytokinesis protein 6 15.46 229.4 
P25054 Adenomatous polyposis coli protein  14.87 311.5 
A0A1B0GVP4 Ligand-dependent nuclear receptor corepressor-like protein  14.77 211.4 
M0R2B3 Uncharacterized protein C19orf44  14.23 68.2 
Q5D862 Filaggrin-2  14.14 247.9 
O60307 Microtubule-associated serine/threonine-protein kinase 3  13.98 143.0 
Q96F05 Uncharacterized protein C11orf24  13.94 46.1 
C9JFF0 Kinesin-like protein KIF26A  13.74 180.0 
Q9UKN1 Mucin-12 13.65 557.8 
C9K0E4 Syntaxin-binding protein 5-like  13.62 111.2 
O75592 E3 ubiquitin-protein ligase MYCBP2  13.48 509.8 
L8E7G9 Alternative protein ZNF74  13.30 32.4 
A6NK89 Ras association domain-containing protein 10  13.28 56.9 
B7Z7S7 
cDNA FLJ60964, weakly similar to Homo sapiens dentin 
sialophosphoprotein (DSPP), mRNA 
13.27 37.7 
B3KWI5 
cDNA FLJ43124 fis, clone CTONG3004072, highly 
similar to Protein EMSY  
13.26 130.7 
E9PG32 Dynein heavy chain 12, axonemal  13.24 454.0 
F5GYR0 Actin-binding LIM protein 2  13.13 71.3 
H0YN99 Pseudopodium-enriched atypical kinase 1  13.13 115.1 
Q9NR48 Histone-lysine N-methyltransferase ASH1L  13.06 332.6 
Q9H5Y7 SLIT and NTRK-like protein 6  13.00 95.0 
Q8TE73 Dynein heavy chain 5, axonemal  12.98 528.7 
A7E2F7 CAP-GLY domain containing linker protein 2  12.95 111.7 
Q5HYC2 Uncharacterized protein KIAA2026  12.85 227.9 
A0A087WV20 Alstrom syndrome protein 1 12.77 425.0 
Q5T1R4 Transcription factor HIVEP3  12.73 259.3 
A7Y9J9 Mucin 5AC, oligomeric mucus/gel-forming  12.59 648.4 
Q96RK0 Protein capicua homolog 12.58 163.7 
A0A0J9YY01 Unconventional myosin-XVB  12.41 333.5 
Q9Y2F5 Little elongation complex subunit 1  12.35 247.7 
A0A087X1X8 Uncharacterized protein 12.31 21.7 
A0A0A0MS59 Helicase SRCAP  12.23 315.4 
A1L4H1 
Soluble scavenger receptor cysteine-rich domain-
containing protein SSC5D 
12.20 165.6 
H7BZX1 Sorbin and SH3 domain-containing protein 2  12.05 27.5 
S6C4Q9 IgG L chain  12.01 22.8 
B4DWY3 
cDNA FLJ56165, highly similar to RNA exonuclease 1 
homolog (EC 3.1.-.-)  
11.79 58.3 
P54274 Telomeric repeat-binding factor  11.68 50.2 
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Q2TAZ0 Autophagy-related protein 2 homolog A  11.55 212.7 
P78310 Coxsackievirus and adenovirus receptor  11.50 40.0 
A6NM62 Leucine-rich repeat-containing protein 53  11.39 140.7 
Q96LR2 Leucine rich adaptor protein 1 11.24 25.8 
K9N2R0 Interleukin 15 receptor alpha isoform IC8 OS=Ho 11.14 30.8 
Q9H2L7 DC33  11.06 29.5 
Q9UHB7 AF4/FMR2 family member 4  10.92 127.4 
Q92766 Ras-responsive element-binding protein 1 10.85 181.3 
Q59GL0 Rearranged L-myc fusion sequence variant  10.64 184.6 
Q7Z4S6 Kinesin-like protein KIF21A 10.60 187.1 
Q6GMQ3 PHC1 protein  10.56 100.1 
Q6KC79 Nipped-B-like protein  10.53 315.9 
A0A087WVZ6 Protein kinase C-binding protein 1  10.51 125.7 
A0A087WXN4 Integrator complex subunit 12  10.51 46.6 
Q6ZU65 Ubinuclein-2  10.41 146.0 
E7EWQ5 Microtubule-associated serine/threonine-protein kinase 4  10.40 266.0 
A0A075B756 Krueppel-like factor 14 10.39 33.1 
F1T0K4 DmX-like protein 1  10.38 318.4 
H3BTR6 RNA-binding protein with serine-rich domain 1  10.36 13.0 
Q2M2I8 AP2-associated protein kinase 1  10.28 103.8 
Q9BXF6 Rab11 family-interacting protein 5 10.26 70.4 
A8KAL3 
cDNA FLJ77478, highly similar to Homo sapiens Rho 
GTPase activating protein 6 (ARHGAP6), transcript 
variant 1, mRNA  
10.24 105.8 
P78409 Butyrophilin 10.20 81.3 
H7C1I7 Zinc finger MYM-type protein 4  10.19 134.3 
Q15772 Striated muscle preferentially expressed protein kinase  10.18 354.1 
A8K5H6 
cDNA FLJ76659, highly similar to Homo sapiens 
exonuclease 1 (EXO1), transcript variant 2, mRNA  
10.14 93.8 
H0YKJ2 Solute carrier family 12 member 6 10.12 14.8 
A0A024QZH6 
Serine arginine-rich pre-mRNA splicing factor SR-A1, 
isoform CRA_a  
10.11 139.2 
Q5T088 MORN repeat-containing protein 1  10.02 19.7 
A0A1W2PR28 IQ motif and SEC7 domain-containing protein 2  10.01 127.9 
Q9H6K5 Proline-rich protein 36  9.98 132.7 
Q5JW04 Solute carrier family 35 member C2  9.98 21.8 
O95425 Supervillin  9.97 247.6 
Q5JPC9 
ABI gene family, member 3 (NESH) binding protein, 
isoform CRA_d  
9.96 110.6 
A0A1W2PRA7 Calcium-activated potassium channel subunit alpha-1 9.96 107.9 
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P16188 HLA class I histocompatibility antigen, A-30 alpha chain 9.96 40.9 
P51826 AF4/FMR2 family member 3  9.93 133.4 
A0A087WU78 Nance-Horan syndrome protein  9.93 157.7 
B4E063 Kinesin-like protein  9.93 73.0 
A0A024RDD6 Uncharacterized protein  9.87 82.4 
Q5VWG9 Transcription initiation factor TFIID subunit 3  9.84 103.5 
Q96JG9 Zinc finger protein 469  9.81 409.9 
Q14690 Protein RRP5 homolog 9.78 208.6 
Q8NFC6 
Biorientation of chromosomes in cell division protein 1-
like 1 
9.78 330.3 
O15457 MutS protein homolog 4  9.76 104.7 
A0A024RB02 
PTPRF interacting protein, binding protein 1 (Liprin beta 
1), isoform CRA_a  
9.75 96.9 
B4DYH4 
cDNA FLJ51571, moderately similar to Mediator of DNA 
damage checkpoint protein 1  
9.75 178.6 
Q5T7P2 Late cornified envelope protein 1A  9.71 11.0 
A0A024R1T4 Trinucleotide repeat containing 6B, isoform CRA_b 9.71 162.1 
Q9C0D5 Protein TANC1  9.68 202.1 
A0A0A0MTR7 E3 ubiquitin-protein ligase RNF213 9.67 591.0 
H0YLX2 DNA-binding protein RFX7  9.65 137.4 
S4R418 Bridging integrator 2  9.63 59.0 
Q9P206 Uncharacterized protein KIAA1522  9.61 107.0 
Q14395 Mucin  9.59 51.9 
B2RWP0 Signal-induced proliferation-associated 1 like 3  9.58 194.5 
A2A2V2 RNA-binding protein 34 9.57 45.9 
A8K119 
cDNA FLJ76742, highly similar to Homo sapiens deleted 
in liver cancer 1 (DLC1), transcript variant 2, mRNA  
9.55 122.7 
X6R7H2 
Peroxisome proliferator-activated receptor gamma 
coactivator-related protein 1 
9.53 69.1 
Q86UU5 Gametogenetin  9.53 66.7 
Q8WY24 SNC66 protein  9.48 53.6 
I0B0K6 Truncated profilaggrin  9.46 277.1 
Q8N122 Regulatory-associated protein of mTOR  9.44 148.9 
Q8NEY1 Neuron navigator 1  9.43 202.3 
Q86YZ3 Hornerin  9.42 282.2 
Q9C0B5 Palmitoyltransferase ZDHHC5  9.41 77.5 
Q64FY1 AKNA transcript B1  9.38 146.2 
E7EPM4 Mucin-17  9.38 425.3 
B7ZKL5 AXIN2 protein  9.34 86.6 
Q59FR9 Fibroblast growth factor 11 variant  9.23 36.4 
  
69 
A0A0A0MSP7 FERM and PDZ domain-containing protein 3  9.18 193.4 
A0A024RDF7 Uncharacterized protein 9.17 130.2 
Q8IZF6 Adhesion G-protein coupled receptor G4  9.17 333.2 
H0Y785 Ankyrin repeat and KH domain-containing protein 1  9.14 107.8 
B8XCX8 EPC1/ASXL2b fusion protein  9.12 201.7 
A0A087WX12 Centrosomal protein kizuna  9.08 49.3 
Q8IZT6 Abnormal spindle-like microcephaly-associated protein  9.07 409.5 
Q5KU26 Collectin-12 9.06 81.5 
P17948 Vascular endothelial growth factor receptor 1  8.97 150.7 
B3KVI8 cDNA FLJ16604 fis, clone TESTI4008097 8.95 157.9 
Q9Y6R7 IgGFc-binding protein 8.87 571.6 
A0A140VJJ5 Testicular tissue protein Li 69  8.79 119.7 
A8K8Q0 
cDNA FLJ78753, highly similar to Homo sapiens zinc 
fingers and homeoboxes 3 (ZHX3), mRNA  
8.76 104.6 
L8E9Z3 Alternative protein HRC  8.45 34.3 
A0A126LB25 Immediate early protein IE2  8.44 164.2 
Q8IY33 MICAL-like protein 2  8.39 97.4 
B3KR06 CLIP-associating protein 2  8.38 49.1 
C9JG08 Uncharacterized protein C2orf16  8.19 598.1 
Q9ULH0 Kinase D-interacting substrate of 220 kDa  8.15 196.4 
E1A689 Mutant Apo B 100  8.09 489.5 
Q12955 Ankyrin-3  7.98 480.1 
Q53QN0 Putative uncharacterized protein GTF3C2  7.78 58.4 
Q96BY7 Autophagy-related protein 2 homolog B  7.75 232.6 
B0QYZ7 Eukaryotic translation initiation factor 4E transporter  7.56 26.0 
Q20BI6 Cystic fibrosis transmembrane conductance regulator  7.50 150.1 
Q96MW7 Tigger transposable element-derived protein 1  7.38 67.3 
B3KWK5 cDNA FLJ43230 fis, clone HCHON2001269 7.36 24.2 
E3W980 Helicase POLQ-like  7.34 116.7 
Q45KX0 Brevideltin 7.33 22.1 
Q8N2C7 Protein unc-80 homolog  7.28 363.2 
B4DYX2 cDNA FLJ51404, highly similar to Netrin receptor DCC  7.27 99.0 
F2Z2B6 Protein Jade-3 7.24 13.1 
B4E2K8 
cDNA FLJ61075, highly similar to Mineralocorticoid 
receptor  
7.17 67.8 
H0YMD1 Low-density lipoprotein receptor  7.14 104.7 
O75132 Zinc finger BED domain-containing protein 4  7.12 130.2 
H0YM61 
Transient receptor potential cation channel subfamily M 
member 1  
7.12 57.3 
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B4DWC0 
cDNA FLJ58290, highly similar to Zinc finger MYM-type 
protein 6  
7.09 96.9 
B4DNH7 
cDNA FLJ60079, highly similar to Tetratricopeptide 
repeat protein 3  
7.09 99.7 
E9PPY5 Mas-related G-protein-coupled receptor member X3  7.08 27.8 
K7EKF7 
Voltage-dependent P/Q-type calcium channel subunit 
alpha-1A  
7.06 98.8 
A0A0U1RQK2 Casein kinase I isoform gamma-1  7.03 15.4 
H0UI11 Dopey family member 1, isoform CRA_a  7.02 255.6 
A2NH55 Immunogobulin kappa, VJ region  7.00 11.9 
Q8N7X0 Androglobin 6.99 189.6 
Q6ZS54 cDNA FLJ45821 fis, clone NT2RP8001584  6.96 79.2 
Q5T4T1 Transmembrane protein 170B 6.96 14.4 
B4E0Q3 
cDNA FLJ51432, highly similar to Dynamin-binding 
protein  
6.96 57.9 
A0A096LNL9 Transcriptional regulator ATRX  6.94 151.6 
Q8N9U0 Tandem C2 domains nuclear protein  6.92 55.2 
A0A087WW06 Tetratricopeptide repeat protein 28 6.92 256.7 
F2Z357 Rap1 GTPase-activating protein 1  6.91 66.9 
B4DMP4 
cDNA FLJ53136, highly similar to Homo sapiens Vac14 
homolog (VAC14), mRNA  
6.91 80.1 
A0A024R952 
Plakophilin 1 (Ectodermal dysplasia/skin fragility 
syndrome), isoform CRA_a 
6.91 80.4 
B4DRA2 cDNA FLJ57828, highly similar to Treacle protein  6.89 93.7 
A8K8T9 
cDNA FLJ77187, highly similar to Homo sapiens cyclin 
B3 (CCNB3), transcript variant 3, mRNA 
6.88 157.8 
B3KX64 cDNA FLJ44873 fis, clone BRAMY2023939 6.87 77.9 
D6RFH5 Folliculin-interacting protein 2  6.86 74.7 
B3KV77 cDNA FLJ16222 fis, clone CTONG3002947 6.85 56.3 
D6RBK6 Type-1 angiotensin II receptor-associated protein  6.85 16.4 
A0A1B0GUW1 
Phosphatidylinositol N-acetylglucosaminyltransferase 
subunit Q  
6.85 6.9 
B3KXH9 cDNA FLJ45423 fis, clone BRHIP3036936 6.84 110.1 
H0YHI8 Protein phosphatase 1 regulatory subunit 12A  6.83 40.6 
B4DG67 
cDNA FLJ58842, highly similar to Homo sapiens zinc and 
ring finger 1 (ZNRF1), mRNA  
6.83 21.8 
Q5SWA1 Protein phosphatase 1 regulatory subunit 15B  6.82 79.1 
B4DLG2 
cDNA FLJ58196, highly similar to Zinc finger CCCH 
domain-containing protein 11A 
6.81 82.7 
Q6ZVL6 UPF0606 protein KIAA1549L  6.81 198.9 
Q6WRX3 Protein zyg-11 homolog A  6.79 85.8 
Q59FL0 Misshapen/NIK-related kinase isoform 2 variant 6.78 93.2 
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D3DTH7 Myosin IC, isoform CRA_a  6.77 98.9 
Q9HBR1 Putative uncharacterized protein 6.77 50.4 
Q71F56 
Mediator of RNA polymerase II transcription subunit 13-
like  
6.77 242.4 
C9J0I9 Nuclear-interacting partner of ALK  6.76 50.5 
Q8N237 cDNA FLJ34965 fis, clone NTONG2004308  6.76 99.0 
A0A024RD26 G protein-coupled receptor 116, isoform CRA_a  6.75 149.3 
S4R3C2 Nucleolar and coiled-body phosphoprotein 1  6.75 29.3 
A0A1W2PPB5 Bone morphogenetic protein receptor type-2  6.74 57.0 
C9JJU3 Bromodomain testis-specific protein  6.74 52.8 
A0A0C4DFX2 Protein furry homolog  6.74 338.0 
Q7Z408 CUB and sushi domain-containing protein 2 6.73 379.8 
G3V1X1 Proline/serine-rich coiled-coil 2, isoform CRA_a  6.72 39.1 
Q68D69 Putative uncharacterized protein DKFZp779G1236 6.72 113.3 
Q9BU23 Lipase maturation factor 2  6.71 79.6 
B2RMV2 CYTSA protein  6.71 124.5 
P08217 Chymotrypsin-like elastase family member 2A  6.71 28.9 
Q5VV42 Threonylcarbamoyladenosine tRNA methylthiotransferase 6.69 65.1 
E7EX48 Serine/threonine-protein kinase Nek4 6.69 80.6 
E9PL24 Myomegalin  6.69 126.9 
Q9C0D2 Centrosomal protein of 295 kDa  6.68 295.0 
A8KAE4 cDNA FLJ75520 6.68 131.2 
C9JN15 Peptidyl-prolyl cis-trans isomerase  6.67 27.4 
C9JG84 Sorbin and SH3 domain-containing protein 2  6.67 12.3 
Q5JPB2 Zinc finger protein 831  6.66 177.8 
Q6NUQ2 Calmin (Calponin-like, transmembrane)  6.66 111.6 
Q9ULL8 Protein Shroom4  6.65 164.8 
H0YBF7 
Arf-GAP with SH3 domain, ANK repeat and PH domain-
containing protein 1  
6.65 105.2 
H9KVB3 Otogelin  6.64 313.2 
A2RQD7 Bcr-abl1 e19a2 chimeric protein  6.64 56.6 
P55291 Cadherin-15  6.64 88.9 
Q53H75 Chromosome 14 open reading frame 133 variant 6.63 57.0 
B4DL51 
cDNA FLJ60657, highly similar to Homo sapiens Smith-
Magenis syndrome chromosome region, candidate 8 
(SMCR8), mRNA  
6.63 75.3 
H3BU24 
S phase cyclin A-associated protein in the endoplasmic 
reticulum 
6.63 6.4 
E9PML0 Cytochrome P450 4B1  6.62 36.4 
A5PLN7 Protein FAM149A  6.61 82.6 
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Q59G99 Dishevelled 1 isoform a variant 6.61 40.3 
A0A140T8X5 STK19  6.61 40.4 
B2R621 
cDNA, FLJ92736, highly similar to Homo sapiens gamma-
aminobutyric acid (GABA) A receptor, alpha 3 
(GABRA3), mRNA  
6.60 55.1 
A6NJB7 Proline-rich protein 19  6.60 38.7 
L8E8M9 Alternative protein PCDHB16 6.60 9.1 
B3KU03 cDNA FLJ39022 fis, clone NT2RP7003724 6.60 64.6 
Q9HCK8 Chromodomain-helicase-DNA-binding protein 8  6.59 290.3 
Q8IYW4 ENTH domain-containing protein 1  6.57 67.5 
Q2VIN3 RBM1  6.57 41.4 
B7ZKN6 UTX protein  6.54 149.2 
F8WAI8 Zinc finger and BTB domain-containing protein 40  6.53 125.4 
Q13489 Baculoviral IAP repeat-containing protein 3  6.52 68.3 
H0Y482 Band 4.1-like protein 1  6.52 13.0 
Q53FJ3 
Ubiquitin specific protease, proto-oncogene isoform a 
variant 
6.52 108.5 
Q7Z540 Mucin short variant SV7  6.50 13.4 
E9PNK1 Sialidase-3 6.50 18.8 
H0YGG9 Solute carrier organic anion transporter family member  6.49 52.7 
Q5M9N0 Coiled-coil domain-containing protein 158 6.48 127.1 
D6RFZ4 Protein FAM193A  6.48 87.2 
Q9P2Q4 5-hydroxytryptamine (Serotonin) receptor 1F  6.48 41.6 
Q68DX6 Putative uncharacterized protein DKFZp686P0776  6.46 78.0 
B0QZ65 
GTPase-activating protein and VPS9 domain-containing 
protein 1  
6.45 56.4 
B4DX00 
cDNA FLJ61440, highly similar to Izumo sperm-egg 
fusion protein 1  
6.45 26.4 
Q9Y6R1 Electrogenic sodium bicarbonate cotransporter 1  6.45 121.4 
Q96GX5 Serine/threonine-protein kinase greatwall 6.44 97.3 
B4E124 Ankyrin repeat and LEM domain-containing protein 1 6.43 46.6 
B4DR76 
cDNA FLJ58249, highly similar to Eukaryotic translation 
initiation factor 4E transporter  
6.43 68.9 
A8K482 Aspartate aminotransferase  6.43 47.5 
Q8IY92 Structure-specific endonuclease subunit SLX4  6.43 199.9 
Q7Z2Z1 Treslin  6.43 210.7 
Q8N397 Putative uncharacterized protein DKFZp761M142  6.42 89.8 
Q9H195 Mucin-3B  6.42 131.3 
B3KUT9 
cDNA FLJ40599 fis, clone THYMU2011183, highly 
similar to Thymus-specific serine protease (EC3.4.-.-)  
6.41 27.5 
A7MD48 Serine/arginine repetitive matrix protein 4  6.41 68.5 
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A0A1B0GTR8 
Ankyrin repeat and fibronectin type-III domain-containing 
protein 1  
6.40 56.4 
B7Z5R7 
cDNA FLJ61355, highly similar to CLIP-associating 
protein 1  
6.40 135.7 
Q8IX28 SE2-5LT1 protein  6.39 89.6 
O43147 Small G protein signaling modulator 2  6.39 113.2 
B4DNH6 Perilipin  6.39 38.4 
F8VY01 FYVE, RhoGEF and PH domain-containing protein 6  6.39 135.4 
B2RU27 Testis expressed 15 6.38 315.1 
Q9ULK2 Ataxin-7-like protein 1 6.38 91.5 
A0A1W2PQT4 KAT8 regulatory NSL complex subunit 1  6.38 58.4 
A6ND36 Protein FAM83G  6.36 90.8 
Q8N4A7 Putative uncharacterized protein 6.36 8.0 
Q9BX26 Synaptonemal complex protein 2  6.35 175.5 
H0YCA1 Plasma protease C1 inhibitor  6.34 9.9 
B3KS23 cDNA FLJ35336 fis, clone PROST2015464 6.34 56.4 
A0A1S5UZH2 Protein-methionine sulfoxide oxidase  6.34 116.8 
G0Z071 Sex-determining region Y protein  6.33 23.8 
L8E9J7 Alternative protein GPR78  6.33 9.6 
B5MCY1 Tudor domain-containing protein 15  6.32 221.6 
H0YAA7 Endomucin 6.32 8.0 
Q8WYX5 Putative uncharacterized protein pp10472 6.31 17.9 
I3L209 
Transforming growth factor beta-1-induced transcript 1 
protein  
6.31 6.5 
Q53TA0 Receptor protein-tyrosine kinase  6.30 79.0 
H7BXS9 Trinucleotide repeat-containing gene 18 protein  6.29 42.6 
H0Y5R1 
Aryl hydrocarbon receptor nuclear translocator-like protein 
2  
6.29 65.6 
Q9BRL6 Serine/arginine-rich splicing factor 8  6.23 32.3 
Q96KW2 POM121-like protein 2  6.23 109.8 
H0Y7V4 Dynein heavy chain 8, axonemal 6.23 478.6 
A0A075B7B7 GAS2-like protein 2 6.19 94.8 
B6RC65 Epidermal growth factor receptor variant EX12_14del  6.18 15.0 
B4DDG9 
cDNA FLJ53856, highly similar to 5-aminolevulinate 
synthase, nonspecific, mitochondrial (EC 2.3.1.37) 
6.17 48.8 
Q684P5 Rap1 GTPase-activating protein 2  6.16 80.0 
Q9UBL0 cAMP-regulated phosphoprotein 21  6.15 89.1 
Q9BW04 Specifically androgen-regulated gene protein 6.15 63.9 
A0A0G2JN42 Mucin-6  6.14 256.9 
Q2XPN4 Mitochondrial A kinase PPKA anchor protein 10  6.08 67.7 
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Q9UND0 Killer inhibitory receptor 2-2-1  6.06 14.3 
E7EU81 Golgin subfamily B member 1 6.05 188.1 
H0UIC5 Ecotropic viral integration site 2B, isoform CRA_a  6.04 39.9 
B4E1T1 
cDNA FLJ54081, highly similar to Keratin, type II 
cytoskeletal 5 
6.04 58.8 
P46013 Proliferation marker protein Ki-67  6.04 358.5 
O43419 Intestinal mucin  6.02 60.5 
Q9NWN3 F-box only protein 34  6.02 78.7 
A0A024R8E8 Senataxin, isoform CRA_b  6.01 199.9 
B7Z5J1 
cDNA FLJ59265, highly similar to NAD-dependent 
deacetylase sirtuin-3, mitochondrial (EC 3.5.1.-) 
6.01 37.6 
B3KME0 cDNA FLJ10760 fis, clone NT2RP3004618 6.01 88.7 
Q59FF8 CUB and Sushi multiple domains 1 variant  6.00 323.3 
A0A024R3H2 
Sortilin-related receptor, L(DLR class) A repeats-
containing, isoform CRA_b 
5.98 248.3 
E9PHY1 Low-density lipoprotein receptor-related protein 5 5.96 52.4 
C9JT44 Solute carrier family 25 member 38  5.95 16.6 
B3KR17 cDNA FLJ33465 fis, clone BRAMY2001367 5.94 86.5 
Q6ZR29 cDNA FLJ46702 fis, clone TRACH3014183 5.91 160.1 
D6RDI1 E3 ubiquitin-protein ligase MIB2  5.90 11.6 
Q05DV5 ZC3HAV1 protein  5.90 49.2 
B4DS83 cDNA FLJ53179, highly similar to Nucleolar protein 10  5.88 74.4 
D2CPJ9 
Mutant mutant xeroderma pigmentosum complementation 
group C protein  
5.84 25.7 
Q6ZU64 Cilia- and flagella-associated protein 65  5.83 217.1 
B2R8T0 
cDNA, FLJ94049, highly similar to Homo sapiens egf-like 
module containing, mucin-like, hormonereceptor-like 
sequence 1 (EMR1), mRNA 
5.82 97.7 
A8K857 cDNA FLJ76361  5.82 23.5 
B7Z7H2 
cDNA FLJ58079, highly similar to Homo sapiens SH3 
multiple domains 1 (SH3MD1), mRNA  
5.81 106.3 
P0C7P2 Putative protein RFPL3S 5.81 11.7 
H0YLM8 DmX-like protein 2  5.80 132.6 
B4DG65 
cDNA FLJ52105, highly similar to PDZ domain-
containing RING finger protein 4  
5.79 89.0 
K4DI93 Cullin 4B, isoform CRA_e  5.71 102.7 
A8K601 cDNA FLJ75186  5.70 118.4 
B7Z3E3 Reticulon  5.69 100.8 
P27815 cAMP-specific 3',5'-cyclic phosphodiesterase 4A 5.69 98.1 
A0A1B0GTP3 Long intergenic non-protein coding RNA 238  5.64 18.9 
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Q86U11 
Full-length cDNA clone CS0DE006YM09 of Placenta of 
Homo sapiens (human) 
5.47 47.7 
A0A0B4J2E9 
High affinity immunoglobulin epsilon receptor subunit 
beta  
5.30 21.6 
K7EIU2 Serine/threonine-protein kinase ULK2  5.26 21.0 
B2R7I0 
cDNA, FLJ93451, highly similar to Homo sapiens 
thioredoxin domain containing 14 (TXNDC14), mRNA  
5.23 34.0 
Q5VSN0 SH3 domain-containing kinase-binding protein 1  5.22 61.4 
A0A087WVA8 Testis-expressed protein 2  5.22 125.3 
F8WF20 Integrin beta-1-binding protein 1  5.21 4.3 
F5GYN0 Protein FAM186A  5.09 262.1 
B3KN94 cDNA FLJ13982 fis, clone Y79AA1001711 5.05 62.0 
E9PBD8 Lymphocyte-specific protein 1  4.85 24.4 
Q59EZ3 Insulin-like growth factor 2 receptor variant  4.69 265.9 
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Table 3.  Overlapping pellicle proteins present on metallic brackets surface (BMQ), ceramic brackets 
(CBMQ) and HA discs (DMQ) 
BMQ/CBMQ/DMQ 
Accession 
Number 
Description (protein name)  
Peptides 
Identification  
MW 
[kDa] 
calc. 
pI 
Total: 9 P02814 
Submaxillary gland 
androgen-regulated protein 
3B   
2 8.2 9.57 
 F5GZK2 Collagen alpha-1(XXI)   3 99.2 8.47 
 Q8WXI7 Mucin-16  14 1518.2 5.26 
 E9PAV3 
Nascent polypeptide-
associated complex subunit 
alpha  
6 205.3 9.58 
 Q7Z5P9 Mucin-19  7 804.8 5.01 
 Q5VST9 Obscurin   3 867.9 5.99 
 Q9NR48 
Histone-lysine N-
methyltransferase ASH1L  
3 332.6 9.39 
 Q8IVF2 Protein AHNAK2  3 616.2 5.36 
 C9JFF0 Kinesin-like protein KIF26A  2 180 8.9 
BMQ/CBMQ 
Accession 
Number 
Description (protein name)  
Peptides 
Identification  
MW 
[kDa] 
calc. 
pI 
Total: 18 P13645 Keratin, type I cytoskeletal 10  13 58.8 5.21 
 H6VRF8 Keratin 1  13 66 8.12 
 P35527 Keratin, type I cytoskeletal 9    7 62 5.24 
 Q92954 Proteoglycan 4  3 151 9.5 
 Q5CZC0 
Fibrous sheath-interacting 
protein 2  
7 780.1 6.71 
 A0A0J9Y
YJ7 
Unconventional myosin-XVB  3 79.5 9.61 
 A8K781 cDNA FLJ75299  3 47.3 5.22 
 Q8WXG9 G-protein coupled receptor 98  4 692.6 4.64 
 Q96HA1 
Nuclear envelope pore 
membrane protein POM 121 
2 127.6 
10.5
6 
 J3KQ96 Treacle protein  3 144 8.29 
 B7ZLW1 CAMSAP1 protein   3 163.2 6.95 
 I0B0K8 Truncated profilaggrin 3 430.2 9.29 
 Q8WVS4 
WD repeat-containing protein 
60  
3 122.5 7.31 
 Q8NB66 Protein unc-13 homolog C  3 250.8 5.92 
 B4E223 cDNA FLJ52075 2 68.5 9.85 
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 F5GX59 
Zonadhesin   
2 282.2 5.96 
 A4PB67 YY1AP-related protein1  2 248.2 5.01 
 Q5TAX3 
Terminal uridylyltransferase 
4   
2 185 7.97 
BMQ/CBMQ 
Accession 
Number 
Description (protein name)  
Peptides 
Identification  
MW 
[kDa] 
calc. 
pI 
Total: 36  P15515 Histatin-1  2 7 9.14 
 A2A2V2 RNA-binding protein 34  2 45.9 
10.0
8 
 T1R7N3 MUC5AC  4 413.6 8.09 
 Q5SYE7 NHS-like protein 1  4 170.6 6.96 
 Q86YZ3 Hornerin  4 282.2 
10.0
4 
 B8XCX8 EPC1/ASXL2b fusion protein 5 201.7 8.53 
 B4DH81 cDNA FLJ61250 2 93.5 6.92 
 P51826 AF4/FMR2 family member 3  3 133.4 8.1 
 Q8IVL0 Neuron navigator 3  4 255.5 8.76 
 Q6ZU65  Ubinuclein-2  3 146 9.19 
 O75592 
E3 ubiquitin-protein ligase 
MYCBP2  
4 509.8 7.03 
 A0A1W2
PR28 
 IQ motif and SEC7 domain-
containing protein 2  
3 127.9 6.96 
 Q96JG9 Zinc finger protein 469  3 409.9 7.72 
 Q5T4S7 
E3 ubiquitin-protein ligase 
UBR4  
3 573.5 6.04 
 X6R7H2 
Peroxisome proliferator-
activated receptor gamma 
coactivator-related protein 1  
3 69.1 
10.0
4 
 Q96F05 
Uncharacterized protein 
C11orf24 
2 46.1 5.87 
 Q59G99 
Dishevelled 1 isoform a 
variant 
2 40.3 8.24 
 E7EPM4 Mucin-17  3 425.3 4.03 
 P46013 
Proliferation marker protein 
Ki-67  
3 358.5 9.45 
 Q9HCK8 
Chromodomain-helicase-
DNA-binding protein 8  
2 290.3 6.47 
 Q5VWG9 
Transcription initiation factor 
TFIID subunit 3  
3 103.5 9.06 
 P25054 
Adenomatous polyposis coli 
protein  
3 311.5 7.8 
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 A0A140V
JJ5 
Testicular tissue protein Li 69  2 119.7 9.39 
 Q9UKN1 Mucin-12  2 557.8 5.55 
 O60307 
Microtubule-associated 
serine/threonine-protein 
kinase 3  
2 143 8.06 
 E9PL24 Myomegalin  2 126.9 5.27 
 Q96KW2 POM121-like protein 2  2 109.8 9.89 
 L8E9Z3 Alternative protein HRC  2 34.3 
11.9
9 
 Q9C0D2 
Centrosomal protein of 295 
kDa  
2 295 6 
 B2RWP0 
Signal-induced proliferation-
associated 1 like 3  
2 194.5 8.32 
 A0A024R
DF7 
Uncharacterized protein  2 194.5 7.8 
 Q5T1R4 Transcription factor HIVEP3  2 259.3 7.81 
 B7Z7H2 cDNA FLJ58079 2 106.3 8.44 
CBMQ/DMQ 
Accession 
Number 
Description (protein name)  
Peptides 
Identification  
MW 
[kDa] 
calc. 
pI 
Total: 11 H0Y5R1 
Aryl hydrocarbon receptor 
nuclear translocator-like 
protein 2  
2 65.6 7.8 
 Q5JPC9 
ABI gene family, member 3 
(NESH) binding protein, 
isoform CRA_d 
3 110.6 10.1 
 E1A689 Mutant Apo B 100 2 489.5 7.1 
 H3BTR6 
RNA-binding protein with 
serine-rich domain 1  
3 12.9 11.2 
 B2RMV2 CYTSA protein 2 124.5 5.7 
 A0A024Q
ZH6 
Serine arginine-rich pre-
mRNA splicing factor SR-
A1, isoform CRA_a 
3 139.1 9.2 
 A0A024R
DD6 
Uncharacterized protein  3 82.3 7.5 
 A0A087W
W06 
Tetratricopeptide repeat 
protein 28  
2 256.7 6.8 
 T1R7N3 MUC5AC  6 413.6 8 
 J3KNQ2 
Fibronectin type III domain-
containing protein 1  
6 194.4 9.2 
 P01036 Cystatin-S  3 16.2 5 
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Table 4.  The Twenty more abundant proteins present in each group (metallic brackets surface (BMQ), 
ceramic brackets (CBMQ) and HA discs (DMQ)) with their respective pI 
BMQ 
Accession 
Number  
Description (protein 
name)  
Ion 
count 
score 
Coverage  
Peptides 
Identification  
MW 
[kDa] 
calc. 
pI 
20 of 
298 
found 
P13645 
Keratin, type I 
cytoskeletal 10  
263.77 33.90 13 58.8 5.21 
  A0A0A0MTS7 Titin     175.26 1.26 25 3992.2 6.39 
  H6VRF8 Keratin 1  175.13 27.48 13 66.0 8.12 
  P02814 
Submaxillary gland 
androgen-regulated 
protein 3B   
105.99 65.82 2 8.2 9.57 
  P35527 
Keratin, type I 
cytoskeletal 9  
96.87 25.84 7 62.0 5.24 
  P35908 
Keratin, type II 
cytoskeletal 2 
epidermal  
96.10 45.23 14 65.4 8.00 
  M0R088 
Serine/arginine 
repetitive matrix 
protein 1  
59.52 6.75 5 78.1 12.06 
  Q6ZRI6 
Uncharacterized 
protein C15orf39  
56.38 4.49 2 110.6 7.64 
  P15515 Histatin-1  54.31 36.84 2 7.0 9.13 
  B3KXW2 
cDNA FLJ46178 fis, 
clone TESTI4003944  
50.78 4.15 3 141.6 8.65 
  F5GZK2 
Collagen alpha-
1(XXI)   
49.95 3.77 3 99.2 8.47 
  Q8WXI7 Mucin-16  47.89 2.55 14 1518.2 5.26 
  Q96RT6 
cTAGE family 
member 2  
41.43 4.97 2 85.2 6.16 
  B4DRU6 
cDNA FLJ54657, 
highly similar to 
Keratin, type II 
cytoskeletal 6A  
39.88 12.39 5 58.5 7.37 
  Q92954 Proteoglycan 4  39.63 4.42 3 151.0 9.50 
  Q5CZC0 
Fibrous sheath-
interacting protein 2  
34.44 2.01 7 780.1 6.71 
  B4DVQ0 
cDNA FLJ58286, 
highly similar to 
Actin, cytoplasmic 2  
33.09 13.51 3 37.3 5.71 
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  A0A0J9YYJ7 
Unconventional 
myosin-XVB  
32.86 9.47 3 79.5 9.61 
  A2A2V2 
RNA-binding protein 
34  
32.18 3.68 2 45.9 10.08 
  B3KNX8 
cDNA FLJ30689 fis, 
clone 
FCBBF2000566  
30.34 10.65 3 84.5 6.28 
CBMQ 
Accession 
Number  
Description (protein 
name)  
Ion 
count 
score 
Coverage  
Peptides 
Identification  
MW 
[kDa] 
calc. 
pI 
20 of 
154 
found  
P04745 Alpha-amylase 1  606.56 57.34 21 57.7 6.93 
  F6KPG5 Albumin  166.66 18.63 11 66.5 6.04 
  P02814 
Submaxillary gland 
androgen-regulated 
protein 3B  
165.02 65.82 2 8.2 9.57 
  P06702 Protein S100-A9  160.46 73.68 7 13.2 6.13 
  Q6PJF2 IGK@ protein   137.04 29.36 6 25.5 6.55 
  C0JYZ2 Titin  129.49 0.77 13 3711.4 6.52 
  P01833 
Polymeric 
immunoglobulin 
receptor  
121.67 16.23 9 83.2 5.74 
  P01036 Cystatin-S  116.55 53.19 6 16.2 5.02 
  P01037 Cystatin-SN  95.10 56.74 6 16.4 7.21 
  A0A0C4DGN4 
Zymogen granule 
protein 16 homolog B  
88.79 43.26 4 19.6 5.95 
  P23280 Carbonic anhydrase 6  88.59 25.00 5 35.3 7.02 
  P25311 
Zinc-alpha-2-
glycoprotein  
86.75 28.19 5 34.2 6.05 
  H6VRF8 Keratin 1  79.25 17.24 8 66.0 8.12 
  P12273 
Prolactin-inducible 
protein  
68.47 26.03 4 16.6 8.05 
  Q8WXI7 Mucin-16  60.58 3.41 18 1518.2 5.26 
  P0DOX7 
Immunoglobulin 
kappa light chain  
59.06 33.18 5 23.4 7.17 
  P05109 Protein S100-A8  56.20 38.71 4 10.8 7.03 
  P06733 Alpha-enolase  54.12 30.88 7 47.1 7.39 
  P01876 
Immunoglobulin 
heavy constant alpha 
1  
50.62 20.96 4 37.6 6.51 
  E7ER44 Lactotransferrin  50.07 13.14 5 77.9 8.12 
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DMQ 
Accession 
Number  
Description (protein 
name)  
Ion 
count 
score 
Coverage  
Peptides 
Identification  
MW 
[kDa] 
calc. 
pI 
20 of 
356 
found  
Q8WXI7 Mucin-16  82.02 3.96 22 1518.2 5.26 
  P15515 Histatin-1  68.85 36.84 2 7.0 9.13 
  B7ZMD7 Alpha-amylase  66.23 29.16 8 57.7 6.93 
  D3DPG0 Titin, isoform CRA_a  65.09 0.93 15 3878.8 6.38 
  P02814 
Submaxillary gland 
androgen-regulated 
protein 3B  
61.25 65.82 2 8.2 9.57 
  Q7Z5P9 Mucin-19  50.38 6.05 15 804.8 5.01 
  B3KY63 
cDNA FLJ16830 fis, 
clone 
UTERU3022536  
43.22 4.77 5 215.1 5.90 
  F5GZK2 
Collagen alpha-
1(XXI) chain  
37.05 2.93 2 99.2 8.47 
  P01036 Cystatin-S  33.12 32.62 3 16.2 5.02 
  A0A0U1RR20 Proteoglycan 4  30.51 10.43 7 146.4 9.47 
  Q86VQ1 
Glucocorticoid-
induced transcript 1 
protein  
29.92 15.54 4 58.0 9.44 
  E9PAV3 
Nascent polypeptide-
associated complex 
subunit alpha, 
muscle-specific form  
24.97 10.49 7 205.3 9.58 
  Q5VST9 Obscurin  22.78 1.90 5 867.9 5.99 
  H0Y465 Neurofibromin  20.65 2.88 2 281.0 7.28 
  T1S9D5 MUC5AC  20.41 4.51 6 521.3 7.11 
  T1R7N3 MUC5AC  20.12 7.13 6 413.6 8.09 
  B4DH81 cDNA FLJ61250  19.95 4.74 2 93.5 6.92 
  B3KY54 cDNA FLJ46886  19.84 5.48 2 61.6 7.75 
  Q5SYE7 NHS-like protein 1  19.49 5.90 4 170.6 6.96 
  Q9UQ35 
Serine/arginine 
repetitive matrix 
protein 2  
19.23 5.78 6 299.4 12.06 
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Table 5. The 20 more abundant proteins on metallic and ceramic brackets categorized by biological function related to dental caries 
  BMQ CBMQ 
Function of 
proteins  
Description Accession Description Accession 
Antimicrobial 
Mucin-16  Q8WXI7 Mucin-16  Q8WXI7 
Histatin-1 P15515 Cystatin-S  P01036 
  
Cystatin-SN P01037 
Immunoglobulin heavy constant 
alpha 1 
P01876 
Immunoglobulin kappa light chain  P0DOX7 
Polymeric immunoglobulin 
receptor  
P01833 
Protein S100-A9  P06702 
Protein S100-A8  P05109 
Lactotransferrin  E7ER44 
Lubrication 
Mucin-16  Q8WXI7 Mucin-16  Q8WXI7 
Proteoglycan 4  Q92954     
Remineralizati
on  
Histatin-1 P15515 
Protein S100-A9  P06702 
Protein S100-A8  P05109 
early dental 
plaque 
formation  
    Alpha-amylase 1  P04745 
Inflammatory 
response  
  
Albumin  F6KPG5 
Protein S100-A9  P06702 
Protein S100-A8  P05109 
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Tissue 
formation/ 
protein-protein 
interaction  
Keratin, type I cytoskeletal 10  P13645     
Titin     
A0A0A0MT
S7 
Carbonic anhydrase 6  P23280 
Keratin 1  H6VRF8 Zinc-alpha-2-glycoprotein  P25311 
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Figure 1. XPS wide scan spectrum of metallic brackets surface pre-treated with distilled water  
 
 
 
 
 
 
  
 
Figure 2. XPS wide scan spectrum of ceramic orthodontic brackets surfaces pre-treated with distilled water  
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Figure 3. Venn diagram of acquired pellicle proteins identified in each material surface group 
and across groups. BMQ: metallic orthodontic bracket, CBMQ: Ceramic orthodontic bracket, 
DMQ: HA discs   
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Appendix 3: Material safety data sheet from Orthodontic company  
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